cached image

Neil K. Aaronson - Publications

Affiliations: 
Clinical Psychology University of Amsterdam, Amsterdam, Netherlands 
Area:
health-related quality of life
Website:
http://www.nki.nl/people/aaronson-neil/

391 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Billingy NE, N M F Tromp V, Aaronson NK, Hoek RJA, Bogaard HJ, Onwuteaka-Philipsen BD, van de Poll-Franse L, Hugtenburg JG, Belderbos J, Becker-Commissaris A, van den Hurk CJG, Walraven I. Quality of life after patient-initiated versus physician-initiated response to symptom monitoring: the SYMPRO-Lung trial. Journal of the National Cancer Institute. PMID 37603720 DOI: 10.1093/jnci/djad159  0.326
2023 Wagner C, Witt JH, Nolte S, van der Poel HG, Aaronson NK, Kolvatzis M, Tian Z, Mendrek M, Liakos N, Gratzke C, Leyh-Bannurah SR. Differences in Quality of Life between German and Dutch Patients with Prostate Cancer Treated with Robot-assisted Radical Prostatectomy: Implications for International Multicenter Randomized Controlled Trials. European Urology Focus. PMID 36863963 DOI: 10.1016/j.euf.2023.02.007  0.329
2022 Cocks K, Wells JR, Johnson C, Schmidt H, Koller M, Oerlemans S, Velikova G, Pinto M, Tomaszewski KA, Aaronson NK, Exall E, Finbow C, Fitzsimmons D, Grant L, Groenvold M, et al. Content validity of the EORTC quality of life questionnaire QLQ-C30 for use in cancer. European Journal of Cancer (Oxford, England : 1990). 178: 128-138. PMID 36436330 DOI: 10.1016/j.ejca.2022.10.026  0.376
2022 Hiensch AE, Monninkhof EM, Schmidt ME, Zopf EM, Bolam KA, Aaronson NK, Belloso J, Bloch W, Clauss D, Depenbusch J, Lachowicz M, Pelaez M, Rundqvist H, Senkus E, Stuiver MM, et al. Design of a multinational randomized controlled trial to assess the effects of structured and individualized exercise in patients with metastatic breast cancer on fatigue and quality of life: the EFFECT study. Trials. 23: 610. PMID 35906659 DOI: 10.1186/s13063-022-06556-7  0.354
2022 van Leeuwen M, Kieffer JM, Young TE, Aaronson NK, van de Poll-Franse LV. Correction to: Phase III study of the European Organisation for Research and Treatment of Cancer Quality of Life cancer survivorship core questionnaire. Journal of Cancer Survivorship : Research and Practice. PMID 35277836 DOI: 10.1007/s11764-022-01199-8  0.315
2022 van Leeuwen M, Kieffer JM, Young TE, Aaronson NK, van de Poll-Franse LV. Phase III study of the European Organisation for Research and Treatment of Cancer Quality of Life cancer survivorship core questionnaire. Journal of Cancer Survivorship : Research and Practice. PMID 35088246 DOI: 10.1007/s11764-021-01160-1  0.354
2021 Ripping TM, Westhoff E, Aaronson NK, Van Hemelrijck M, Rammant E, Witjes JA, Kiemeney LA, Aben KKH, Vrieling A. Validation and reliability of the Dutch version of the EORTC QLQ-NMIBC24 Questionnaire Module for patients with non-muscle-invasive bladder cancer. Journal of Patient-Reported Outcomes. 5: 96. PMID 34542736 DOI: 10.1186/s41687-021-00372-4  0.314
2020 Abrahams HJG, Knoop H, Schreurs M, Aaronson NK, Jacobsen PB, Newton RU, Courneya KS, Aitken JF, Arving C, Brandberg Y, Chambers SK, Gielissen MFM, Glimelius B, Goedendorp MM, Graves KD, et al. Moderators of the effect of psychosocial interventions on fatigue in women with breast cancer and men with prostate cancer: Individual patient data meta-analyses. Psycho-Oncology. 29: 1772-1785. PMID 33448521 DOI: 10.1002/Pon.5522  0.385
2020 Coomans MB, Taphoorn MJB, Aaronson NK, Baumert BG, van den Bent M, Bottomley A, Brandes AA, Chinot O, Coens C, Gorlia T, Herrlinger U, Keime-Guibert F, Malmström A, Martinelli F, Stupp R, et al. Measuring change in health-related quality of life: the impact of different analytical methods on the interpretation of treatment effects in glioma patients. Neuro-Oncology Practice. 7: 668-675. PMID 33304601 DOI: 10.1093/Nop/Npaa033  0.38
2020 Løppenthin K, Johansen C, Larsen MB, Forchhammer BH, Brennum J, Piil K, Aaronson N, Rasmussen BK, Bidstrup P. Depressive Symptoms in Danish Patients With Glioma and a Cancer-Free Comparison Group. Journal of the National Comprehensive Cancer Network : Jnccn. 18: 1222-1229. PMID 32886907 DOI: 10.6004/Jnccn.2020.7570  0.326
2020 Pilz MJ, Aaronson NK, Arraras JI, Caocci G, Efficace F, Groenvold M, Holzner B, van Leeuwen M, Loth FLC, Petersen MA, Ramage J, Tomaszewski KA, Young T, Giesinger JM. Evaluating the Thresholds for Clinical Importance of the EORTC QLQ-C15-PAL in Patients Receiving Palliative Treatment. Journal of Palliative Medicine. PMID 32835601 DOI: 10.1089/Jpm.2020.0159  0.377
2020 Berns A, Ringborg U, Celis JE, Heitor M, Aaronson NK, Abou-Zeid N, Adami HO, Apostolidis K, Baumann M, Bardelli A, Bernards R, Brandberg Y, Caldas C, Calvo F, Dive C, et al. Towards a cancer mission in Horizon Europe: recommendations. Molecular Oncology. 14: 1589-1615. PMID 32749074 DOI: 10.1002/1878-0261.12763  0.35
2020 Signorelli C, Wakefield CE, McLoone JK, Mateos MK, Aaronson NK, Lavoipierre A, Cohn RJ, Alvaro F. A cost-effective approach to increasing participation in patient reported outcomes research in cancer: A randomized trial of video invitations. International Journal of Cancer. PMID 32748404 DOI: 10.1002/Ijc.33244  0.341
2020 Wollersheim BM, van Asselt KM, van der Poel HG, van Weert HCPM, Hauptmann M, Retèl VP, Aaronson NK, van de Poll-Franse LV, Boekhout AH. Design of the PROstate cancer follow-up care in Secondary and Primary hEalth Care study (PROSPEC): a randomized controlled trial to evaluate the effectiveness of primary care-based follow-up of localized prostate cancer survivors. Bmc Cancer. 20: 635. PMID 32641023 DOI: 10.1186/S12885-020-07112-9  0.356
2020 Buffart LM, Schreurs MAC, Abrahams HJG, Kalter J, Aaronson NK, Jacobsen PB, Newton RU, Courneya KS, Armes J, Arving C, Braamse AM, Brandberg Y, Dekker J, Ferguson RJ, Gielissen MF, et al. Effects and moderators of coping skills training on symptoms of depression and anxiety in patients with cancer: Aggregate data and individual patient data meta-analyses. Clinical Psychology Review. 80: 101882. PMID 32640368 DOI: 10.1016/J.Cpr.2020.101882  0.323
2020 Cottone F, Collins GS, Anota A, Sommer K, Giesinger JM, Kieffer JM, Aaronson NK, Van Steen K, Charton E, Castagnetti F, Fazi P, Vignetti M, Cella D, Efficace F. Time to health-related quality of life improvement analysis was developed to enhance evaluation of modern anticancer therapies. Journal of Clinical Epidemiology. PMID 32562837 DOI: 10.1016/J.Jclinepi.2020.06.016  0.442
2020 Giesinger JM, Blazeby J, Aaronson NK, Sprangers M, Fayers P, Sparano F, Rees J, Anota A, Wan C, Pezold M, Isharwal S, Cottone F, Efficace F. Differences in Patient-Reported Outcomes That Are Most Frequently Detected in Randomized Controlled Trials in Patients With Solid Tumors: A Pooled Analysis of 229 Trials. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 23: 666-673. PMID 32389233 DOI: 10.1016/J.Jval.2020.02.007  0.424
2020 Wollersheim BM, van Stam MA, Bosch RJLH, Pos FJ, Tillier CN, van der Poel HG, Aaronson NK. Unmet expectations in prostate cancer patients and their association with decision regret. Journal of Cancer Survivorship : Research and Practice. PMID 32385837 DOI: 10.1007/S11764-020-00888-6  0.33
2020 Husson O, de Rooij BH, Kieffer J, Oerlemans S, Mols F, Aaronson NK, van der Graaf WTA, van de Poll-Franse LV. The EORTC QLQ-C30 Summary Score as Prognostic Factor for Survival of Patients with Cancer in the "Real-World": Results from the Population-Based PROFILES Registry. The Oncologist. 25: e722-e732. PMID 32297435 DOI: 10.1634/Theoncologist.2019-0348  0.447
2020 Bjelic-Radisic V, Cardoso F, Cameron D, Brain E, Kuljanic K, da Costa RA, Conroy T, Inwald EC, Serpentini S, Pinto M, Weis J, Morag O, Lindviksmoen Astrup G, Tomaszewksi KA, Pogoda K, ... ... Aaronson N, et al. Corrigendum to An international update of the EORTC questionnaire for assessing quality of life in breast cancer patients: EORTC QLQ-BR45: Ann Oncol 2020; Volume 31, Issue 2, Pages 283-288. Annals of Oncology : Official Journal of the European Society For Medical Oncology. PMID 32089397 DOI: 10.1016/J.Annonc.2020.02.001  0.444
2020 Ten Tusscher MR, Groen WG, Geleijn E, Berkelaar D, Aaronson NK, Stuiver MM. Education Needs of Dutch Physical Therapists for the Treatment of Patients With Advanced Cancer: A Mixed Methods Study. Physical Therapy. PMID 32031218 DOI: 10.1093/Ptj/Pzz172  0.443
2020 Bjelic-Radisic V, Cardoso F, Cameron D, Brain E, Kuljanic K, da Costa RA, Conroy T, Inwald EC, Serpentini S, Pinto M, Weis J, Morag O, Lindviksmoen Astrup G, Tomaszweksi KA, Pogoda K, ... ... Aaronson N, et al. An international update of the EORTC questionnaire for assessing quality of life in breast cancer patients: EORTC QLQ-BR45. Annals of Oncology : Official Journal of the European Society For Medical Oncology. 31: 283-288. PMID 31959345 DOI: 10.1016/J.Annonc.2019.10.027  0.464
2020 Petersen MA, Aaronson NK, Conroy T, Costantini A, Giesinger JM, Hammerlid E, Holzner B, Johnson CD, Kieffer JM, van Leeuwen M, Nolte S, Ramage JK, Tomaszewski KA, Waldmann A, Young T, et al. International validation of the EORTC CAT Core: a new adaptive instrument for measuring core quality of life domains in cancer. Quality of Life Research : An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation. PMID 31955374 DOI: 10.1007/S11136-020-02421-9  0.438
2020 Atema V, van Leeuwen M, Kieffer JM, Oldenburg HSA, van Beurden M, Hunter MS, Aaronson NK. Internet-based cognitive behavioral therapy aimed at alleviating treatment-induced menopausal symptoms in breast cancer survivors: Moderators and mediators of treatment effects. Maturitas. 131: 8-13. PMID 31787152 DOI: 10.1016/J.Maturitas.2019.09.007  0.337
2019 Verhaak E, Gehring K, Hanssens PEJ, Aaronson NK, Sitskoorn MM. Health-related quality of life in adult patients with brain metastases after stereotactic radiosurgery: a systematic, narrative review. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. PMID 31792879 DOI: 10.1007/S00520-019-05136-X  0.403
2019 Lo-Fo-Wong DNN, de Haes HCJM, Aaronson NK, van Abbema DL, den Boer MD, van Hezewijk M, Immink M, Kaptein AA, Menke-Pluijmers MBE, Reyners AKL, Russell NS, Schriek M, Sijtsema S, van Tienhoven G, Verdam MGE, et al. Risk factors of unmet needs among women with breast cancer in the post-treatment phase. Psycho-Oncology. PMID 31785043 DOI: 10.1002/Pon.5299  0.326
2019 Sommer K, Cottone F, Aaronson NK, Fayers P, Fazi P, Rosti G, Angelucci E, Gaidano G, Venditti A, Voso MT, Baccarani M, Vignetti M, Efficace F. Consistency matters: measurement invariance of the EORTC QLQ-C30 questionnaire in patients with hematologic malignancies. Quality of Life Research : An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation. PMID 31782016 DOI: 10.1007/S11136-019-02369-5  0.434
2019 Gehring K, Stuiver MM, Visser E, Kloek C, van den Bent M, Hanse M, Tijssen C, Rutten GJ, Taphoorn MJB, Aaronson NK, Sitskoorn MM. A pilot randomized controlled trial of exercise to improve cognitive performance in patients with stable glioma: a proof of concept. Neuro-Oncology. PMID 31755917 DOI: 10.1093/Neuonc/Noz178  0.302
2019 Sparano F, Aaronson NK, Sprangers MAG, Fayers P, Pusic A, Kieffer JM, Cottone F, Rees J, Pezold M, Anota A, Charton E, Vignetti M, Wan C, Blazeby J, Efficace F. Inclusion of older patients with cancer in randomised controlled trials with patient-reported outcomes: a systematic review. Bmj Supportive & Palliative Care. PMID 31719051 DOI: 10.1136/Bmjspcare-2019-001902  0.393
2019 Efficace F, Cottone F, Sommer K, Kieffer J, Aaronson N, Fayers P, Groenvold M, Caocci G, Coco FL, Gaidano G, Niscola P, Baccarani M, Rosti G, Venditti A, Angelucci E, et al. Validation of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 Summary Score in Patients With Hematologic Malignancies. Value in Health. 22: 1303-1310. PMID 31708068 DOI: 10.1016/J.Jval.2019.06.004  0.408
2019 Giesinger JM, Loth FLC, Aaronson NK, Arraras JI, Caocci G, Efficace F, Groenvold M, van Leeuwen M, Petersen MA, Ramage J, Tomaszewski KA, Young T, Holzner B. Thresholds for clinical importance were defined for the EORTC CAT Core - an adaptive measure of core quality of life domains in oncology clinical practice and research. Journal of Clinical Epidemiology. PMID 31593797 DOI: 10.1016/J.Jclinepi.2019.09.028  0.327
2019 Brédart A, Anota A, Dick J, Cano A, De Pauw A, Kop JL, Aaronson NK, Bleiker EM, Brunet J, Devilee P, Stoppa-Lyonnet D, Schmutzler R, Dolbeault S. The "Psychosocial Aspects in Hereditary Cancer" questionnaire in women attending breast cancer genetic clinics: Psychometric validation across French-, German- and Spanish-language versions. European Journal of Cancer Care. e13173. PMID 31571365 DOI: 10.1111/Ecc.13173  0.379
2019 van Vulpen JK, Sweegers MG, Peeters PHM, Courneya KS, Newton RU, Aaronson NK, Jacobsen PB, Galvão DA, Chinapaw MJ, Steindorf K, Irwin ML, Stuiver MM, Hayes S, Griffith KA, Mesters I, et al. Moderators of Exercise Effects on Cancer-related Fatigue: A Meta-analysis of Individual Patient Data. Medicine and Science in Sports and Exercise. PMID 31524827 DOI: 10.1249/Mss.0000000000002154  0.348
2019 Lo-Fo-Wong DN, de Haes HC, Aaronson NK, van Abbema DL, Admiraal JM, den Boer MD, Hezewijk MV, Immink M, Kaptein AA, Menke-Pluijmers MB, Russell NS, Schriek M, Sijtsema S, van Tienhoven G, Sprangers MA. Health care use and remaining needs for support among women with breast cancer in the first 15 months after diagnosis: the role of the GP. Family Practice. PMID 31504455 DOI: 10.1093/Fampra/Cmz043  0.309
2019 Verbeek JGE, Atema V, Mewes JC, van Leeuwen M, Oldenburg HSA, van Beurden M, Hunter MS, van Harten WH, Aaronson NK, Retèl VP. Cost-utility, cost-effectiveness, and budget impact of Internet-based cognitive behavioral therapy for breast cancer survivors with treatment-induced menopausal symptoms. Breast Cancer Research and Treatment. PMID 31451978 DOI: 10.1016/J.Jval.2019.09.274  0.315
2019 Bernard P, Savard J, Steindorf K, Sweegers MG, Courneya KS, Newton RU, Aaronson NK, Jacobsen PB, May AM, Galvao DA, Chinapaw MJ, Stuiver MM, Griffith KA, Mesters I, Knoop H, et al. Effects and moderators of exercise on sleep in adults with cancer: Individual patient data and aggregated meta-analyses. Journal of Psychosomatic Research. 124: 109746. PMID 31443811 DOI: 10.1016/J.Jpsychores.2019.109746  0.312
2019 Sweegers MG, Boyle T, Vallance JK, Chinapaw MJ, Brug J, Aaronson NK, D'Silva A, Kampshoff CS, Lynch BM, Nollet F, Phillips SM, Stuiver MM, van Waart H, Wang X, Buffart LM, et al. Which cancer survivors are at risk for a physically inactive and sedentary lifestyle? Results from pooled accelerometer data of 1447 cancer survivors. The International Journal of Behavioral Nutrition and Physical Activity. 16: 66. PMID 31420000 DOI: 10.1186/S12966-019-0820-7  0.351
2019 Smith TG, Dunn ME, Levin KY, Tsakraklides SP, Mitchell SA, van de Poll-Franse LV, Ward KC, Wiggins CL, Wu XC, Hurlbert M, Aaronson NK. Cancer survivor perspectives on sharing patient-generated health data with central cancer registries. Quality of Life Research : An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation. PMID 31399859 DOI: 10.1007/S11136-019-02263-0  0.417
2019 Koole SN, van Lieshout C, van Driel WJ, van Schagen E, Sikorska K, Kieffer JM, Schagen van Leeuwen JH, Schreuder HWR, Hermans RH, de Hingh IH, van der Velden J, Arts HJ, Massuger LFAG, Aalbers AG, Verwaal VJ, ... ... Aaronson NK, et al. Cost Effectiveness of Interval Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy in Stage III Ovarian Cancer on the Basis of a Randomized Phase III Trial. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1900594. PMID 31251694 DOI: 10.1097/01.Ogx.0000580484.27329.5A  0.334
2019 Koole SN, Kieffer JM, K Sikorska, Schagen van Leeuwen JH, Schreuder HWR, Hermans RH, de Hingh IH, van der Velden J, Arts HJ, van Ham MAPC, Aalbers AG, Verwaal VJ, Van de Vijver KK, Sonke GS, van Driel WJ, ... Aaronson NK, et al. Health-related quality of life after interval cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with stage III ovarian cancer. European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. PMID 31128948 DOI: 10.1016/J.Ejso.2019.05.006  0.423
2019 Agasi-Idenburg CS, Zuilen MK, Westerman MJ, Punt CJA, Aaronson NK, Stuiver MM. "I am busy surviving" - Views about physical exercise in older adults scheduled for colorectal cancer surgery. Journal of Geriatric Oncology. PMID 31122871 DOI: 10.1016/J.Jgo.2019.05.001  0.346
2019 Yu EY, Nekeman D, Aaronson NK, Billingham LJ, James ND, Cheng KK, Bryan RT, Wesselius A, Zeegers MP. Health-Related Quality of Life in Bladder Cancer Patients around the Time of Diagnosis. Bju International. PMID 31077532 DOI: 10.1111/bju.14804  0.348
2019 Agasi-Idenburg SC, Punt CJA, Aaronson NK, Stuiver MM. The association between preoperative fatigue and instrumental activities in daily living with complications and length of hospital stay in patients undergoing colorectal surgery. Aging Clinical and Experimental Research. 32: 257-264. PMID 30997661 DOI: 10.1007/S40520-019-01199-2  0.312
2019 van der Hout A, Neijenhuijs KI, Jansen F, van Uden-Kraan CF, Aaronson NK, Groenvold M, Holzner B, Terwee CB, van de Poll-Franse LV, Cuijpers P, Verdonck-de Leeuw IM. Measuring health-related quality of life in colorectal cancer patients: systematic review of measurement properties of the EORTC QLQ-CR29. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. PMID 30982095 DOI: 10.1007/S00520-019-04764-7  0.447
2019 van Maarschalkerweerd PEA, Schaapveld M, Paalman CH, Aaronson NK, Duijts SFA. Changes in employment status, barriers to, and facilitators of (return to) work in breast cancer survivors 5-10 years after diagnosis. Disability and Rehabilitation. 1-7. PMID 30907148 DOI: 10.1080/09638288.2019.1583779  0.316
2019 van Osch FHM, Nekeman D, Aaronson NK, Billingham LJ, James ND, Cheng KK, Bryan RT, Zeegers MP. Patients choose certainty over burden in bladder cancer surveillance. World Journal of Urology. PMID 30903352 DOI: 10.1007/S00345-019-02728-4  0.356
2019 Sparano F, Aaronson NK, Cottone F, Piciocchi A, La Sala E, Anota A, Deliu N, Kieffer JM, Efficace F. Clinician-reported symptomatic adverse events in cancer trials: are they concordant with patient-reported outcomes? Journal of Comparative Effectiveness Research. PMID 30838883 DOI: 10.2217/Cer-2018-0092  0.376
2019 Atema V, van Leeuwen M, Kieffer JM, Oldenburg HSA, van Beurden M, Gerritsma MA, Kuenen MA, Plaisier PW, Lopes Cardozo AMF, van Riet YEA, Heuff G, Rijna H, van der Meij S, Noorda EM, Timmers GJ, ... ... Aaronson NK, et al. Efficacy of Internet-Based Cognitive Behavioral Therapy for Treatment-Induced Menopausal Symptoms in Breast Cancer Survivors: Results of a Randomized Controlled Trial. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1800655. PMID 30763176 DOI: 10.1200/Jco.18.00655  0.392
2019 Ten Tusscher MR, Groen WG, Geleijn E, Sonke GS, Konings IR, Van der Vorst MJ, van Zweeden A, Aaronson NK, Stuiver MM. Physical problems, functional limitations, and preferences for physical therapist-guided exercise programs among Dutch patients with metastatic breast cancer: a mixed methods study. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. 27: 3061-3070. PMID 30610432 DOI: 10.1007/S00520-018-4619-X  0.332
2019 Sparano F, Aaronson NK, Sprangers MA, Fayers P, Pusic A, Kieffer JM, Rees J, Wan C, Pezold M, Fuzesi S, Isharwal S, Anota A, Charton E, Vignetti M, Cottone F, et al. Does the quality of patient-reported outcomes (PROs) assessment in randomized controlled trials (RCTs) differ across cancer types and over time? A pooled analysis of 610 RCTs published between 2004 and 2018. Journal of Clinical Oncology. 37: e18218-e18218. DOI: 10.1200/Jco.2019.37.15_Suppl.E18218  0.436
2019 Sparano F, Aaronson NK, Sprangers MA, Fayers P, Pusic A, Kieffer JM, Rees J, Wan C, Pezold M, Fuzesi S, Isharwal S, Anota A, Charton E, Vignetti M, Cottone F, et al. Inclusion of patient-reported outcomes (PROs) in randomized controlled trials (RCTs) with elderly cancer patients: A systematic review. Journal of Clinical Oncology. 37: e18217-e18217. DOI: 10.1200/Jco.2019.37.15_Suppl.E18217  0.403
2019 Coomans M, Dirven L, Bottomley A, van den Bent M, Sloan J, Stupp R, Weller M, Reijneveld JC, Taphoorn M, Aaronson N, Baumert BG, Brandes AA, Chinot O, Coens C, Gorlia T, et al. OS7.4 Calculating the net clinical benefit in brain tumor clinical trials by combining survival and health-related quality of life data using two methods: quality adjusted survival effect sizes (QASES) and joint modelling (JM) Neuro-Oncology. 21: iii14-iii15. DOI: 10.1093/Neuonc/Noz126.047  0.403
2019 Coomans M, Taphoorn MJB, Aaronson N, Baumert BG, van den Bent M, Bottomley A, Brandes AA, Chinot O, Coens C, Gorlia T, Herrlinger U, Keime-Guibert F, Malmström A, Martinelli F, Stupp R, et al. OS7.2 Measuring change in health-related quality of life: the added value of analysis on the individual patient level in glioma patients in clinical decision making Neuro-Oncology. 21: iii14-iii14. DOI: 10.1093/Neuonc/Noz126.045  0.398
2019 Dirven L, Petersen MA, Aaronson NK, Chie W, Conroy T, Costantini A, Hammerlid E, Velikova G, Leeuw IMV, Young T, Groenvold M. Development and Psychometric Evaluation of an Item Bank for Computerized Adaptive Testing of the EORTC Insomnia Dimension in Cancer Patients (EORTC CAT-SL) Applied Research in Quality of Life. 1-18. DOI: 10.1007/S11482-019-09799-W  0.409
2018 van Stam MA, Aaronson NK, Bosch JLHR, Kieffer JM, van der Voort van Zyp JRN, Tillier CN, Horenblas S, van der Poel HG. Patient-reported Outcomes Following Treatment of Localised Prostate Cancer and Their Association with Regret About Treatment Choices. European Urology Oncology. PMID 31411965 DOI: 10.1016/J.Euo.2018.12.004  0.366
2018 Nolte S, Liegl G, Petersen MA, Aaronson NK, Costantini A, Fayers PM, Groenvold M, Holzner B, Johnson CD, Kemmler G, Tomaszewski KA, Waldmann A, Young TE, Rose M. General population normative data for the EORTC QLQ-C30 health-related quality of life questionnaire based on 15,386 persons across 13 European countries, Canada and the Unites States. European Journal of Cancer (Oxford, England : 1990). 107: 153-163. PMID 30576971 DOI: 10.1016/J.Ejca.2018.11.024  0.425
2018 Liegl G, Petersen MA, Groenvold M, Aaronson NK, Costantini A, Fayers PM, Holzner B, Johnson CD, Kemmler G, Tomaszewski KA, Waldmann A, Young TE, Rose M, Nolte S. Establishing the European Norm for the health-related quality of life domains of the computer-adaptive test EORTC CAT Core. European Journal of Cancer (Oxford, England : 1990). 107: 133-141. PMID 30576969 DOI: 10.1016/J.Ejca.2018.11.023  0.432
2018 Lagergren P, Schandl A, Aaronson NK, Adami HO, de Lorenzo F, Denis L, Faithfull S, Liu L, Meunier F, Ulrich C. Cancer survivorship: an integral part of Europe's research agenda. Molecular Oncology. PMID 30552794 DOI: 10.1002/1878-0261.12428  0.399
2018 Sztankay M, Aaronson NK, Arraras JI, Basso U, Bumbasirevic U, Efficace F, Giesinger JM, Johnson CD, van Leeuwen M, Oberguggenberger AS, Sosnowski R, Young T, Holzner B. International phase IV validation study of an EORTC quality of life questionnaire for testicular cancer patients: the EORTC QLQ-TC26. Bmc Cancer. 18: 1104. PMID 30419889 DOI: 10.1186/S12885-018-5036-8  0.473
2018 van de Wiel HJ, Stuiver MM, May AM, van Grinsven S, Aaronson NK, Retèl VP, Oldenburg HSA, van der Poel HG, Horenblas S, van Harten WH, Groen WG. (Cost-)effectiveness of an internet-based physical activity support program (with and without physiotherapy counselling) on physical activity levels of breast and prostate cancer survivors: design of the PABLO trial. Bmc Cancer. 18: 1073. PMID 30400784 DOI: 10.1186/S12885-018-4927-Z  0.347
2018 Buffart LM, Sweegers MG, May AM, Chinapaw MJ, van Vulpen JK, Newton RU, Galvão DA, Aaronson NK, Stuiver MM, Jacobsen PB, Verdonck-de Leeuw IM, Steindorf K, Irwin ML, Hayes S, Griffith KA, et al. Targeting Exercise Interventions to Patients With Cancer in Need: An Individual Patient Data Meta-Analysis. Journal of the National Cancer Institute. PMID 30299508 DOI: 10.1093/Jnci/Djy161  0.411
2018 Sweegers MG, Altenburg TM, Brug J, May AM, van Vulpen JK, Aaronson NK, Arbane G, Bohus M, Courneya KS, Daley AJ, Galvao DA, Garrod R, Griffith KA, Van Harten WH, Hayes SC, et al. Effects and moderators of exercise on muscle strength, muscle function and aerobic fitness in patients with cancer: a meta-analysis of individual patient data. British Journal of Sports Medicine. PMID 30181323 DOI: 10.1136/Bjsports-2018-099191  0.34
2018 Petersen MA, Aaronson NK, Arraras JI, Chie WC, Conroy T, Costantini A, Dirven L, Fayers P, Gamper EM, Giesinger JM, Habets EJJ, Hammerlid E, Helbostad J, Hjermstad MJ, Holzner B, et al. The EORTC CAT Core-The computer adaptive version of the EORTC QLQ-C30 questionnaire. European Journal of Cancer (Oxford, England : 1990). 100: 8-16. PMID 29936066 DOI: 10.1016/J.Ejca.2018.04.016  0.449
2018 van Leeuwen M, Husson O, Alberti P, Arraras JI, Chinot OL, Costantini A, Darlington AS, Dirven L, Eichler M, Hammerlid EB, Holzner B, Johnson CD, Kontogianni M, Kjær TK, Morag O, ... ... Aaronson NK, et al. Understanding the quality of life (QOL) issues in survivors of cancer: towards the development of an EORTC QOL cancer survivorship questionnaire. Health and Quality of Life Outcomes. 16: 114. PMID 29866185 DOI: 10.1186/S12955-018-0920-0  0.482
2018 Neijenhuijs KI, Jansen F, Aaronson NK, Brédart A, Groenvold M, Holzner B, Terwee CB, Cuijpers P, Verdonck-de Leeuw IM. A systematic review of the measurement properties of the European Organisation for Research and Treatment of Cancer In-patient Satisfaction with Care Questionnaire, the EORTC IN-PATSAT32. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. PMID 29732482 DOI: 10.1007/S00520-018-4243-9  0.422
2018 Melissant HC, Neijenhuijs KI, Jansen F, Aaronson NK, Groenvold M, Holzner B, Terwee CB, van Uden-Kraan CF, Cuijpers P, Verdonck-de Leeuw IM. A systematic review of the measurement properties of the Body Image Scale (BIS) in cancer patients. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. PMID 29532245 DOI: 10.1007/S00520-018-4145-X  0.408
2018 van Stam MA, Pieterse AH, van der Poel HG, Bosch JLHR, Tillier C, Horenblas S, Aaronson NK. Shared Decision-Making in Prostate Cancer Care: Encouraging every patient to be actively involved in decision-making, or ensuring patients' preferred level of involvement? The Journal of Urology. PMID 29501555 DOI: 10.1016/J.Juro.2018.02.3091  0.32
2018 Kalter J, Verdonck-de Leeuw IM, Sweegers MG, Aaronson NK, Jacobsen PB, Newton RU, Courneya KS, Aitken JF, Armes J, Arving C, Boersma LJ, Braamse AM, Brandberg Y, Chambers SK, Dekker J, et al. Effects and moderators of psychosocial interventions on quality of life, and emotional and social function in patients with cancer: an individual patient data meta-analysis of 22 RCTs. Psycho-Oncology. PMID 29361206 DOI: 10.1002/Pon.4648  0.411
2018 van Driel WJ, Koole SN, Sikorska K, Schagen van Leeuwen JH, Schreuder HWR, Hermans RHM, de Hingh IHJT, van der Velden J, Arts HJ, Massuger LFAG, Aalbers AGJ, Verwaal VJ, Kieffer JM, Van de Vijver KK, van Tinteren H, ... Aaronson NK, et al. Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer. The New England Journal of Medicine. 378: 230-240. PMID 29342393 DOI: 10.1056/Nejmoa1708618  0.348
2018 Vulpen Jv, Sweegers M, Peeters PHM, Newton RU, Aaronson NK, Courneya KS, Jacobsen P, Leeuw IV, Brug J, Buffart L, May AM. Effect and moderators of exercise on fatigue in patients with cancer: Meta-analysis of individual patient data. Journal of Clinical Oncology. 36: 104-104. DOI: 10.1200/Jco.2018.36.7_Suppl.104  0.34
2018 Van Amelsfoort R, Walraven I, Jansen EP, Cats A, van Grieken NC, Aaronson NK, Boot H, Lind PA, Meershoek – Klein Kranenbarg E, Nordsmark M, Putter H, Trip AK, van Sandick JW, Sikorska K, van Tinteren H, et al. Quality of life in the CRITICS study, a multicenter randomized phase III trial of neo-adjuvant chemotherapy followed by surgery and chemotherapy or by surgery and chemoradiotherapy in resectable gastric cancer. Journal of Clinical Oncology. 36: 4060-4060. DOI: 10.1200/Jco.2018.36.15_Suppl.4060  0.418
2018 Husson O, de Rooij BH, Kieffer JM, Oerlemans S, Mols F, Aaronson NK, Van Der Graaf WT, van de Poll-Franse L. Independent prognostic value of the EORTC QLQ-C30 summary score on all-cause mortality: Results from the population-based PROFILES registry. Journal of Clinical Oncology. 36: 10070-10070. DOI: 10.1200/Jco.2018.36.15_Suppl.10070  0.391
2018 Bjelic-Radisic V, Bottomley A, Cardoso F, Cameron D, Brain E, Kuljanic K, Costa RAd, Conroy T, Inwald E, Serpentini S, Pinto M, Weis J, Morag O, Astrup GGL, Tomaszweksi K, ... ... Aaronson N, et al. An international update of the EORTC questionnaire for assessing quality of life in breast cancer patients (EORTC QLQ-BC23) - EORTC QLQ-BR45. Annals of Oncology. 29. DOI: 10.1093/Annonc/Mdy270.267  0.448
2018 Sparano F, Aaronson N, Cottone F, Piciocchi A, Sala EL, Anota A, Deliu N, Kieffer JM, Efficace F. Pcn368 - Concordance Between Patients And Clinicians’ Reporting Of Symptomatic Adverse Events In Cancer Clinical Trials: A Systematic Review Value in Health. 21. DOI: 10.1016/J.Jval.2018.09.450  0.373
2017 Dirven L, Taphoorn MJ, Groenvold M, Habets EJ, Aaronson NK, Conroy T, Reijneveld JC, Young T, Petersen MA. Development of an item bank for computerized adaptive testing of self-reported cognitive difficulty in cancer patients. Neuro-Oncology Practice. 4: 189-196. PMID 31385966 DOI: 10.1093/nop/npw026  0.315
2017 King MT, Viney R, Simon Pickard A, Rowen D, Aaronson NK, Brazier JE, Cella D, Costa DSJ, Fayers PM, Kemmler G, McTaggart-Cowen H, Mercieca-Bebber R, Peacock S, Street DJ, Young TA, et al. Australian Utility Weights for the EORTC QLU-C10D, a Multi-Attribute Utility Instrument Derived from the Cancer-Specific Quality of Life Questionnaire, EORTC QLQ-C30. Pharmacoeconomics. PMID 29270835 DOI: 10.1007/S40273-017-0582-5  0.368
2017 Buffart LM, de Bree R, Altena M, van der Werff S, Drossaert CHC, Speksnijder CM, van den Brekel MW, Jager-Wittenaar H, Aaronson NK, Stuiver MM. Demographic, clinical, lifestyle-related, and social-cognitive correlates of physical activity in head and neck cancer survivors. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. PMID 29151175 DOI: 10.1007/S00520-017-3966-3  0.308
2017 van Waart H, Stuiver MM, van Harten WH, Geleijn E, de Maaker-Berkhof M, Schrama J, Geenen MM, Meerum Terwogt JM, van den Heiligenberg SM, Hellendoorn-van Vreeswijk JAJH, Sonke GS, Aaronson NK. Recruitment to and pilot results of the PACES randomized trial of physical exercise during adjuvant chemotherapy for colon cancer. International Journal of Colorectal Disease. PMID 29124329 DOI: 10.1007/S00384-017-2921-6  0.35
2017 Brédart A, Anota A, Young T, Tomaszewski KA, Arraras JI, Moura De Albuquerque Melo H, Schmidt H, Friend E, Bergenmar M, Costantini A, Vassiliou V, Hureaux J, Marchal F, Tomaszewska IM, Chie WC, ... ... Aaronson NK, et al. Phase III study of the European Organisation for Research and Treatment of Cancer satisfaction with cancer care core questionnaire (EORTC PATSAT-C33) and specific complementary outpatient module (EORTC OUT-PATSAT7). European Journal of Cancer Care. PMID 29094784 DOI: 10.1111/Ecc.12786  0.416
2017 van Stam MA, van der Poel HG, van der Voort van Zyp JRN, Tillier CN, Horenblas S, Aaronson NK, Bosch JLHR. The accuracy of patients' perceptions of the risks associated with localized prostate cancer treatments. Bju International. PMID 28960827 DOI: 10.1111/Bju.14034  0.341
2017 Sweegers MG, Altenburg TM, Chinapaw MJ, Kalter J, Verdonck-de Leeuw IM, Courneya KS, Newton RU, Aaronson NK, Jacobsen PB, Brug J, Buffart LM. Which exercise prescriptions improve quality of life and physical function in patients with cancer during and following treatment? A systematic review and meta-analysis of randomised controlled trials. British Journal of Sports Medicine. PMID 28954800 DOI: 10.1136/Bjsports-2017-097891  0.417
2017 Giesinger JM, Aaronson NK, Arraras JI, Efficace F, Groenvold M, Kieffer JM, Loth FLC, Petersen MA, Ramage J, Tomaszewski KA, Young T, Holzner B. A cross-cultural convergent parallel mixed methods study of what makes a cancer-related symptom or functional health problem clinically important. Psycho-Oncology. PMID 28857424 DOI: 10.1002/Pon.4548  0.407
2017 Wevers MR, Aaronson NK, Bleiker EMA, Hahn DEE, Brouwer T, van Dalen T, Theunissen EB, van Ooijen B, de Roos MA, Borgstein PJ, Vrouenraets BC, Vriens E, Bouma WH, Rijna H, Vente JP, et al. Rapid genetic counseling and testing in newly diagnosed breast cancer: Patients' and health professionals' attitudes, experiences, and evaluation of effects on treatment decision making. Journal of Surgical Oncology. PMID 28703900 DOI: 10.1002/Jso.24763  0.364
2017 Le-Rademacher J, Kanwar R, Seisler D, Pachman DR, Qin R, Abyzov A, Ruddy KJ, Banck MS, Lavoie Smith EM, Dorsey SG, Aaronson NK, Sloan J, Loprinzi CL, Beutler AS. Patient-reported (EORTC QLQ-CIPN20) versus physician-reported (CTCAE) quantification of oxaliplatin- and paclitaxel/carboplatin-induced peripheral neuropathy in NCCTG/Alliance clinical trials. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. PMID 28634656 DOI: 10.1007/S00520-017-3780-Y  0.439
2017 van Leeuwen M, Kieffer JM, Efficace F, Fosså SD, Bolla M, Collette L, Colombel M, De Giorgi U, Holzner B, van de Poll-Franse LV, van Poppel H, White J, de Wit R, Osanto S, Aaronson NK, et al. International evaluation of the psychometrics of health-related quality of life questionnaires for use among long-term survivors of testicular and prostate cancer. Health and Quality of Life Outcomes. 15: 97. PMID 28490338 DOI: 10.1186/S12955-017-0670-4  0.449
2017 van Stam MA, van der Poel HG, Bosch JLHR, Tillier CN, Horenblas S, Mols F, Aaronson NK. Prevalence and correlates of mental health problems in prostate cancer survivors: A case-control study comparing survivors with general population peers. Urologic Oncology. PMID 28457651 DOI: 10.1016/J.Urolonc.2017.03.028  0.315
2017 Berntsen S, Aaronson NK, Buffart L, Börjeson S, Demmelmaier I, Hellbom M, Hojman P, Igelström H, Johansson B, Pingel R, Raastad T, Velikova G, Åsenlöf P, Nordin K. Design of a randomized controlled trial of physical training and cancer (Phys-Can) - the impact of exercise intensity on cancer related fatigue, quality of life and disease outcome. Bmc Cancer. 17: 218. PMID 28347291 DOI: 10.1186/S12885-017-3197-5  0.367
2017 Wakefield CE, Fardell JE, Doolan EL, Aaronson NK, Jacobsen PB, Cohn RJ, King M. Participation in psychosocial oncology and quality-of-life research: a systematic review. The Lancet. Oncology. 18: e153-e165. PMID 28271870 DOI: 10.1016/S1470-2045(17)30100-6  0.384
2017 Hummel SB, van Lankveld JJ, Oldenburg HS, Hahn DE, Kieffer JM, Gerritsma MA, Kuenen MA, Bijker N, Borgstein PJ, Heuff G, Lopes Cardozo AM, Plaisier PW, Rijna H, van der Meij S, van Dulken EJ, ... ... Aaronson NK, et al. Efficacy of Internet-Based Cognitive Behavioral Therapy in Improving Sexual Functioning of Breast Cancer Survivors: Results of a Randomized Controlled Trial. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2016696021. PMID 28240966 DOI: 10.1200/Jco.2016.69.6021  0.313
2017 Atema V, van Leeuwen M, Oldenburg HS, van Beurden M, Hunter MS, Aaronson NK. An Internet-based cognitive behavioral therapy for treatment-induced menopausal symptoms in breast cancer survivors: results of a pilot study. Menopause (New York, N.Y.). PMID 28195994 DOI: 10.1097/Gme.0000000000000836  0.324
2017 Van Driel W, Sikorska K, Schagen van Leeuwen J, Schreuder H, Hermans R, de Hingh I, Van Der Velden J, Arts HJ, Leon M, Aalbers A, Victor J. V, van der Vijver K, Aaronson NK, Sonke GS. A phase 3 trial of hyperthermic intraperitoneal chemotherapy (HIPEC) for ovarian cancer. Journal of Clinical Oncology. 35: 5519-5519. DOI: 10.1200/Jco.2017.35.15_Suppl.5519  0.37
2017 Coomans M, Dirven L, Aaronson N, Baumert BG, van den Bent M, Bottomley A, Brandes A, Chinot O, Coens C, Gorlia T, Herrlinger U, Keime-Guibert F, Malmström A, Martinelli F, Stupp R, et al. QLIF-27. THE ADDED VALUE OF HEALTH-RELATED QUALITY OF LIFE (HRQoL) AS A PROGNOSTIC INDICATOR OF OVERALL SURVIVAL AND PROGRESSION FREE SURVIVAL IN GLIOMA PATIENTS: A META-ANALYSIS BASED ON INDIVIDUAL PATIENT DATA FROM RANDOMIZED CONTROLLED TRIALS Neuro-Oncology. 19: vi207-vi207. DOI: 10.1093/Neuonc/Nox168.836  0.374
2017 Koole S, van Driel W, Kieffer J, Sikorska K, van Leeuwen JS, Schreuder H, Hermans R, de Hingh I, van der Velden J, Arts H, Massuger L, Aalbers A, Verwaal V, Van de Vijver K, Aaronson N, et al. Health-related quality of life after hyperthermic intraperitoneal chemotherapy (HIPEC) for stage III ovarian cancer: Results of the phase III OVHIPEC study Annals of Oncology. 28: v627. DOI: 10.1093/Annonc/Mdx440.037  0.392
2017 Hummel L, Van Lankveld J, Oldenburg H, Hahn D, Kieffer J, Gerritsma M, Kuenen M, Bijker N, Borgstein P, Heuff G, Lopes Cardozo A, Plaisier P, Rijna H, Van der Meij S, Van Dulken E, ... ... Aaronson N, et al. Efficacy of internet-based cognitive behavioral therapy in improving sexual functioning of breast cancer survivors with a DSM-IV diagnosis of sexual dysfunction: results of a randomized controlled trial European Journal of Cancer. 72: S7-S8. DOI: 10.1016/S0959-8049(17)30105-3  0.305
2017 Atema V, Van Leeuwen M, Oldenburg H, Van Beurden M, Hunter M, Aaronson N. Internet-based cognitive behavioral therapy to alleviate treatment-induced menopausal symptoms in breast cancer survivors: Results of the EVA-online pilot study Maturitas. 100: 161-162. DOI: 10.1016/J.Maturitas.2017.03.152  0.322
2016 Groenvold M, Aaronson NK, Darlington AE, Fitzsimmons D, Greimel E, Holzner B, Reijneveld JC, Tomaszewski KA, Verdonck-de Leeuw I, van de Poll-Franse L. Focusing on Core Patient-Reported Outcomes in Cancer Clinical Trials-Letter. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 22: 5617. PMID 28151714 DOI: 10.1158/1078-0432.Ccr-16-1529  0.393
2016 Groen WG, Oldenburg HS, Wouters MW, Aaronson NK, van Harten WH. Evaluation of an interactive portal for breast cancer survivors: Use, satisfaction, and preliminary effects. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 34: 200. PMID 28151198 DOI: 10.1200/Jco.2016.34.3_Suppl.200  0.374
2016 Kuijpers W, Oldenburg HS, Wouters MW, Aaronson NK, van Harten WH. Feasibility and preliminary efficacy of an interactive portal for lung cancer patients. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 34: 201. PMID 28151197 DOI: 10.1200/Jco.2016.34.3_Suppl.201  0.433
2016 Buffart LM, Kalter J, Sweegers MG, Courneya KS, Newton RU, Aaronson NK, Jacobsen PB, May AM, Galvão DA, Chinapaw MJ, Steindorf K, Irwin ML, Stuiver MM, Hayes S, Griffith KA, et al. Effects and moderators of exercise on quality of life and physical function in patients with cancer: An individual patient data meta-analysis of 34 RCTs. Cancer Treatment Reviews. 52: 91-104. PMID 28006694 DOI: 10.1016/J.Ctrv.2016.11.010  0.385
2016 Atema V, van Leeuwen M, Oldenburg HS, Retèl V, van Beurden M, Hunter MS, Aaronson NK. Design of a randomized controlled trial of Internet-based cognitive behavioral therapy for treatment-induced menopausal symptoms in breast cancer survivors. Bmc Cancer. 16: 920. PMID 27887581 DOI: 10.1186/S12885-016-2946-1  0.311
2016 Mols F, van de Poll-Franse LV, Vreugdenhil G, Beijers AJ, Kieffer JM, Aaronson NK, Husson O. Reference data of the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-CIPN20 Questionnaire in the general Dutch population. European Journal of Cancer (Oxford, England : 1990). 69: 28-38. PMID 27814471 DOI: 10.1016/J.Ejca.2016.09.020  0.413
2016 Agasi-Idenburg SC, Thong MS, Punt CJ, Stuiver MM, Aaronson NK. Comparison of symptom clusters associated with fatigue in older and younger survivors of colorectal cancer. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. 25: 625-632. PMID 27770205 DOI: 10.1007/S00520-016-3451-4  0.335
2016 Ediebah DE, Reijneveld JC, Taphoorn MJ, Coens C, Zikos E, Aaronson NK, Heimans JJ, Bottomley A, Klein M. Impact of neurocognitive deficits on patient-proxy agreement regarding health-related quality of life in low-grade glioma patients. Quality of Life Research : An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation. PMID 27744512 DOI: 10.1007/S11136-016-1426-Z  0.429
2016 Wintner LM, Sztankay M, Aaronson N, Bottomley A, Giesinger JM, Groenvold M, Petersen MA, van de Poll-Franse L, Velikova G, Verdonck-de Leeuw I, Holzner B. The use of EORTC measures in daily clinical practice-A synopsis of a newly developed manual. European Journal of Cancer (Oxford, England : 1990). 68: 73-81. PMID 27721057 DOI: 10.1016/J.Ejca.2016.08.024  0.403
2016 Brédart A, Beaudeau A, Young T, Moura De Alberquerque Melo H, Arraras JI, Friend L, Schmidt H, Tomaszewski KA, Bergenmar M, Anota A, Costantini A, Marchal F, Tomaszewska IM, Vassiliou V, Chie WC, ... ... Aaronson NK, et al. The European organization for research and treatment of cancer - satisfaction with cancer care questionnaire: revision and extended application development. Psycho-Oncology. PMID 27546090 DOI: 10.1002/Pon.4127  0.364
2016 Lo-Fo-Wong DN, de Haes HC, Aaronson NK, van Abbema DL, den Boer MD, van Hezewijk M, Immink M, Kaptein AA, Menke-Pluijmers MB, Reyners AK, Russell NS, Schriek M, Sijtsema S, van Tienhoven G, Sprangers MA. Predictors of enduring clinical distress in women with breast cancer. Breast Cancer Research and Treatment. PMID 27417105 DOI: 10.1007/S10549-016-3896-7  0.393
2016 Walraven I, Aaronson N, Sonke JJ, Verheij M, Belderbos J. Adverse event development in clinical oncology trials. The Lancet. Oncology. 17: e263. PMID 27396639 DOI: 10.1016/S1470-2045(16)30197-8  0.311
2016 Lo-Fo-Wong DN, de Haes HC, Aaronson NK, van Abbema DL, den Boer MD, van Hezewijk M, Immink M, Kaptein AA, Menke-Pluijmers MB, Reyners AK, Russell NS, Schriek M, Sijtsema S, van Tienhoven G, Sprangers MA. Don't forget the dentist: Dental care use and needs of women with breast cancer. Breast (Edinburgh, Scotland). 29: 1-7. PMID 27376886 DOI: 10.1016/J.Breast.2016.06.012  0.323
2016 Giesinger JM, Kuijpers W, Young T, Tomaszewski KA, Friend E, Zabernigg A, Holzner B, Aaronson NK. Thresholds for clinical importance for four key domains of the EORTC QLQ-C30: physical functioning, emotional functioning, fatigue and pain. Health and Quality of Life Outcomes. 14: 87. PMID 27267486 DOI: 10.1186/S12955-016-0489-4  0.343
2016 Gamper EM, Petersen MA, Aaronson N, Costantini A, Giesinger JM, Holzner B, Kemmler G, Oberguggenberger A, Singer S, Young T, Groenvold M. Development of an item bank for the EORTC Role Functioning Computer Adaptive Test (EORTC RF-CAT). Health and Quality of Life Outcomes. 14: 72. PMID 27150974 DOI: 10.1186/S12955-016-0475-X  0.382
2016 Rebers S, Vermeulen E, Brandenburg AP, Stoof TJ, Zupan-Kajcovski B, Bos WJ, Jonker MJ, Bax CJ, van Driel WJ, Verwaal VJ, van den Brekel MW, Grutters JC, Tupker RA, Plusjé L, de Bree R, ... ... Aaronson NK, et al. A Randomised Controlled Trial of Consent Procedures for the Use of Residual Tissues for Medical Research: Preferences of and Implications for Patients, Research and Clinical Practice. Plos One. 11: e0152509. PMID 27028128 DOI: 10.1371/Journal.Pone.0152509  0.322
2016 van Stam MA, Aaronson NK, Pos FJ, Bosch JL, Kieffer JM, Tillier CN, van der Poel HG. The Effect of Salvage Radiotherapy and its Timing on the Health-related Quality of Life of Prostate Cancer Patients. European Urology. PMID 27016464 DOI: 10.1016/J.Eururo.2016.03.010  0.44
2016 Ahmadzadeh A, Yekaninejad MS, Saffari M, Pakpour AH, Aaronson NK. Reliability and Validity of an Iranian Version of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire for Patients with Multiple Myeloma: the EORTC QLQ-MY20. Asian Pacific Journal of Cancer Prevention : Apjcp. 17: 255-9. PMID 26838220 DOI: 10.7314/Apjcp.2016.17.1.255  0.47
2016 King MT, Costa DS, Aaronson NK, Brazier JE, Cella DF, Fayers PM, Grimison P, Janda M, Kemmler G, Norman R, Pickard AS, Rowen D, Velikova G, Young TA, Viney R. QLU-C10D: a health state classification system for a multi-attribute utility measure based on the EORTC QLQ-C30. Quality of Life Research : An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation. PMID 26790428 DOI: 10.1007/S11136-015-1217-Y  0.364
2016 Paalman CH, van Leeuwen FE, Aaronson NK, de Boer AG, van de Poll-Franse L, Oldenburg HS, Schaapveld M. Employment and social benefits up to 10 years after breast cancer diagnosis: a population-based study. British Journal of Cancer. 114: 81-7. PMID 26757424 DOI: 10.1038/Bjc.2015.431  0.33
2016 Verheij M, Jansen EP, Cats A, van Grieken NC, Aaronson NK, Boot H, Lind PA, Meershoek – Klein Kranenbarg E, Nordsmark M, Putter H, Trip AK, van Sandick JW, Sikorska K, van Tinteren H, Van De Velde CJH. A multicenter randomized phase III trial of neo-adjuvant chemotherapy followed by surgery and chemotherapy or by surgery and chemoradiotherapy in resectable gastric cancer: First results from the CRITICS study. Journal of Clinical Oncology. 34: 4000-4000. DOI: 10.1200/Jco.2016.34.15_Suppl.4000  0.316
2016 Claassen Y, De Steur W, Dikken J, Hartgrink H, Jansen E, Trip A, Van Grieken N, Putter H, Meershoek – Klein Kranenberg E, Van Sandick J, Boot H, Cats A, Aaronson N, Sikorska K, Van Tinteren H, et al. 78. Surgicopathological quality control in the CRITICS gastric cancer trial European Journal of Surgical Oncology (Ejso). 42: S98. DOI: 10.1016/J.Ejso.2016.06.084  0.351
2015 Groen WG, Kuijpers W, Oldenburg HS, Wouters MW, Aaronson NK, van Harten WH. Empowerment of Cancer Survivors Through Information Technology: An Integrative Review. Journal of Medical Internet Research. 17: e270. PMID 26614438 DOI: 10.2196/Jmir.4818  0.359
2015 Kuijpers W, Giesinger JM, Zabernigg A, Young T, Friend E, Tomaszewska IM, Aaronson NK, Holzner B. Patients' and health professionals' understanding of and preferences for graphical presentation styles for individual-level EORTC QLQ-C30 scores. Quality of Life Research : An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation. PMID 26353905 DOI: 10.1007/S11136-015-1107-3  0.329
2015 Giesinger JM, Kieffer JM, Fayers PM, Groenvold M, Petersen MA, Scott NW, Sprangers MA, Velikova G, Aaronson NK. Replication and validation of higher order models demonstrated that a summary score for the EORTC QLQ-C30 is robust. Journal of Clinical Epidemiology. PMID 26327487 DOI: 10.1016/J.Jclinepi.2015.08.007  0.4
2015 van Waart H, van Harten WH, Buffart LM, Sonke GS, Stuiver MM, Aaronson NK. Why do patients choose (not) to participate in an exercise trial during adjuvant chemotherapy for breast cancer? Psycho-Oncology. PMID 26282696 DOI: 10.1002/Pon.3936  0.366
2015 Petersen MA, Aaronson NK, Chie WC, Conroy T, Costantini A, Hammerlid E, Hjermstad MJ, Kaasa S, Loge JH, Velikova G, Young T, Groenvold M. Development of an item bank for computerized adaptive test (CAT) measurement of pain. Quality of Life Research : An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation. PMID 26267524 DOI: 10.1007/S11136-015-1069-5  0.322
2015 Blanchin M, Dauchy S, Cano A, Brédart A, Aaronson NK, Hardouin JB. Validation of the French translation-adaptation of the impact of cancer questionnaire version 2 (IOCv2) in a breast cancer survivor population. Health and Quality of Life Outcomes. 13: 110. PMID 26220672 DOI: 10.1186/S12955-015-0301-X  0.391
2015 Rinkel RN, Verdonck-de Leeuw IM, Doornaert P, Buter J, de Bree R, Langendijk JA, Aaronson NK, Leemans CR. Prevalence of swallowing and speech problems in daily life after chemoradiation for head and neck cancer based on cut-off scores of the patient-reported outcome measures SWAL-QOL and SHI. European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (Eufos) : Affiliated With the German Society For Oto-Rhino-Laryngology - Head and Neck Surgery. PMID 26071622 DOI: 10.1007/S00405-015-3680-Z  0.384
2015 Dirven L, van de Poll-Franse LV, Aaronson NK, Reijneveld JC. Controversies in defining cancer survivorship. The Lancet. Oncology. 16: 610-2. PMID 26065599 DOI: 10.1016/S1470-2045(15)70236-6  0.355
2015 Eijzenga W, Bleiker EM, Hahn DE, Van der Kolk LE, Sidharta GN, Aaronson NK. Prevalence and detection of psychosocial problems in cancer genetic counseling. Familial Cancer. 14: 629-36. PMID 25968807 DOI: 10.1007/S10689-015-9809-9  0.351
2015 Hummel SB, van Lankveld JJ, Oldenburg HS, Hahn DE, Broomans E, Aaronson NK. Internet-based cognitive behavioral therapy for sexual dysfunctions in women treated for breast cancer: design of a multicenter, randomized controlled trial. Bmc Cancer. 15: 321. PMID 25927495 DOI: 10.1186/S12885-015-1320-Z  0.301
2015 van Waart H, Stuiver MM, van Harten WH, Geleijn E, Kieffer JM, Buffart LM, de Maaker-Berkhof M, Boven E, Schrama J, Geenen MM, Meerum Terwogt JM, van Bochove A, Lustig V, van den Heiligenberg SM, Smorenburg CH, ... ... Aaronson NK, et al. Effect of Low-Intensity Physical Activity and Moderate- to High-Intensity Physical Exercise During Adjuvant Chemotherapy on Physical Fitness, Fatigue, and Chemotherapy Completion Rates: Results of the PACES Randomized Clinical Trial. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 33: 1918-27. PMID 25918291 DOI: 10.1200/Jco.2014.59.1081  0.345
2015 Wevers MR, Ausems MG, Verhoef S, Bleiker EM, Hahn DE, Brouwer T, Hogervorst FB, van der Luijt RB, van Dalen T, Theunissen EB, van Ooijen B, de Roos MA, Borgstein PJ, Vrouenraets BC, Vriens E, ... ... Aaronson NK, et al. Does rapid genetic counseling and testing in newly diagnosed breast cancer patients cause additional psychosocial distress? results from a randomized clinical trial. Genetics in Medicine : Official Journal of the American College of Medical Genetics. PMID 25905441 DOI: 10.1038/Gim.2015.50  0.373
2015 Kuijpers W, Groen WG, Loos R, Oldenburg HS, Wouters MW, Aaronson NK, van Harten WH. An interactive portal to empower cancer survivors: a qualitative study on user expectations. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. PMID 25876157 DOI: 10.1007/S00520-015-2605-0  0.378
2015 Wevers MR, Schmidt MK, Engelhardt EG, Verhoef S, Hooning MJ, Kriege M, Seynaeve C, Collée M, van Asperen CJ, Tollenaar RA, Koppert LB, Witkamp AJ, Rutgers EJ, Aaronson NK, Rookus MA, et al. Timing of risk reducing mastectomy in breast cancer patients carrying a BRCA1/2 mutation: retrospective data from the Dutch HEBON study. Familial Cancer. PMID 25700605 DOI: 10.1007/S10689-015-9788-X  0.314
2015 Stuiver MM, ten Tusscher MR, Agasi-Idenburg CS, Lucas C, Aaronson NK, Bossuyt PM. Conservative interventions for preventing clinically detectable upper-limb lymphoedema in patients who are at risk of developing lymphoedema after breast cancer therapy. The Cochrane Database of Systematic Reviews. 2: CD009765. PMID 25677413 DOI: 10.1002/14651858.Cd009765.Pub2  0.357
2015 Boele FW, Douw L, Reijneveld JC, Robben R, Taphoorn MJ, Aaronson NK, Heimans JJ, Klein M. Health-related quality of life in stable, long-term survivors of low-grade glioma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 33: 1023-9. PMID 25667287 DOI: 10.1200/Jco.2014.56.9079  0.374
2015 Rinkel RN, Verdonck-de Leeuw IM, de Bree R, Aaronson NK, Leemans CR. Validity of patient-reported swallowing and speech outcomes in relation to objectively measured oral function among patients treated for oral or oropharyngeal cancer. Dysphagia. 30: 196-204. PMID 25622807 DOI: 10.1007/S00455-014-9595-9  0.436
2015 Kuijpers W, Groen WG, Oldenburg HS, Wouters MW, Aaronson NK, van Harten WH. Development of MijnAVL, an Interactive Portal to Empower Breast and Lung Cancer Survivors: An Iterative, Multi-Stakeholder Approach. Jmir Research Protocols. 4: e14. PMID 25614924 DOI: 10.2196/Resprot.3796  0.382
2015 Thamsborg LH, Petersen MA, Aaronson NK, Chie WC, Costantini A, Holzner B, Verdonck-de Leeuw IM, Young T, Groenvold M. Development of a lack of appetite item bank for computer-adaptive testing (CAT). Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. 23: 1541-8. PMID 25394710 DOI: 10.1007/S00520-014-2498-3  0.375
2015 Yekaninejad MS, Pakpour AH, Tadakamadla J, Kumar S, Mosavi SH, Fridlund B, Bottomley A, Aaronson NK. Oral-health-related quality of life in patients with cancer: cultural adaptation and the psychometric testing of the Persian version of EORTC QLQ-OH17. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. 23: 1215-24. PMID 25312650 DOI: 10.1007/S00520-014-2468-9  0.46
2015 Brédart A, Kop JL, Efficace F, Beaudeau A, Brito T, Dolbeault S, Aaronson N. Quality of care in the oncology outpatient setting from patients' perspective: a systematic review of questionnaires' content and psychometric performance Psycho-Oncology. 24: 382-394. PMID 25196048 DOI: 10.1002/Pon.3661  0.422
2015 Costa DS, Aaronson NK, Fayers PM, Pallant JF, Velikova G, King MT. Testing the measurement invariance of the EORTC QLQ-C30 across primary cancer sites using multi-group confirmatory factor analysis. Quality of Life Research : An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation. 24: 125-33. PMID 25193618 DOI: 10.1007/S11136-014-0799-0  0.429
2015 Mewes JC, Steuten LM, Duijts SF, Oldenburg HS, van Beurden M, Stuiver MM, Hunter MS, Kieffer JM, van Harten WH, Aaronson NK. Cost-effectiveness of cognitive behavioral therapy and physical exercise for alleviating treatment-induced menopausal symptoms in breast cancer patients. Journal of Cancer Survivorship : Research and Practice. 9: 126-35. PMID 25179578 DOI: 10.1007/S11764-014-0396-9  0.36
2015 Lundy JJ, Coons SJ, Aaronson NK. Test-Retest Reliability of an Interactive Voice Response (IVR) Version of the EORTC QLQ-C30. The Patient. 8: 165-70. PMID 24958466 DOI: 10.1007/S40271-014-0071-2  0.319
2015 Gehring K, Stuiver M, Rutten G, Taphoorn M, Aaronson N, Sitskoorn M. NCO-04A PILOT RCT ON THE EFFICACY OF E-HEALTH SUPPORTED PHYSICAL EXERCISE TO IMPROVE COGNITIVE FUNCTIONING IN GLIOMA PATIENTS Neuro-Oncology. 17: v146.4-v147. DOI: 10.1093/Neuonc/Nov223.04  0.319
2014 Aaronson NK, Mattioli V, Minton O, Weis J, Johansen C, Dalton SO, Verdonck-de Leeuw IM, Stein KD, Alfano CM, Mehnert A, de Boer A, van de Poll-Franse LV. Beyond treatment - Psychosocial and behavioural issues in cancer survivorship research and practice. Ejc Supplements : Ejc : Official Journal of Eortc, European Organization For Research and Treatment of Cancer ... [Et Al.]. 12: 54-64. PMID 26217166 DOI: 10.1016/J.Ejcsup.2014.03.005  0.412
2014 Boele FW, Zant M, Heine EC, Aaronson NK, Taphoorn MJ, Reijneveld JC, Postma TJ, Heimans JJ, Klein M. The association between cognitive functioning and health-related quality of life in low-grade glioma patients. Neuro-Oncology Practice. 1: 40-46. PMID 26034615 DOI: 10.1093/Nop/Npu007  0.374
2014 Costa DS, Aaronson NK, Fayers PM, Grimison PS, Janda M, Pallant JF, Rowen D, Velikova G, Viney R, Young TA, King MT. Deriving a preference-based utility measure for cancer patients from the European Organisation for the Research and Treatment of Cancer's Quality of Life Questionnaire C30: a confirmatory versus exploratory approach. Patient Related Outcome Measures. 5: 119-29. PMID 25395875 DOI: 10.2147/PROM.S68776  0.312
2014 Stuiver MM, Tusscher MR, van Opzeeland A, Brendeke W, Lindeboom R, Dijkstra PU, Aaronson NK. Psychometric properties of 3 patient-reported outcome measures for the assessment of shoulder disability after neck dissection. Head & Neck. PMID 25224150 DOI: 10.1002/Hed.23859  0.327
2014 Eijzenga W, Aaronson NK, Hahn DE, Sidharta GN, van der Kolk LE, Velthuizen ME, Ausems MG, Bleiker EM. Effect of routine assessment of specific psychosocial problems on personalized communication, counselors’ awareness, and distress levels in cancer genetic counseling practice: a randomized controlled trial. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 32: 2998-3004. PMID 25049325 DOI: 10.1200/Jco.2014.55.4576  0.339
2014 Reeve BB, Mitchell SA, Dueck AC, Basch E, Cella D, Reilly CM, Minasian LM, Denicoff AM, O'Mara AM, Fisch MJ, Chauhan C, Aaronson NK, Coens C, Bruner DW. Recommended patient-reported core set of symptoms to measure in adult cancer treatment trials. Journal of the National Cancer Institute. 106. PMID 25006191 DOI: 10.1093/Jnci/Dju129  0.416
2014 Slort W, Blankenstein AH, Schweitzer BP, Knol DL, van der Horst HE, Aaronson NK, Deliens L. Effectiveness of the palliative care 'Availability, Current issues and Anticipation' (ACA) communication training programme for general practitioners on patient outcomes: a controlled trial. Palliative Medicine. 28: 1036-45. PMID 24951633 DOI: 10.1177/0269216314538302  0.314
2014 van Leeuwen M, Efficace F, FossÃ¥ SD, Bolla M, De Giorgi U, de Wit R, Holzner B, van de Poll-Franse LV, van Poppel H, White J, Collette L, Osanto S, Aaronson NK, et al. Recruiting long-term survivors of European Organisation for Research and Treatment of Cancer phase III clinical trials into quality of life studies: challenges and opportunities. European Journal of Cancer (Oxford, England : 1990). 50: 1957-63. PMID 24820932 DOI: 10.1016/J.Ejca.2014.04.018  0.414
2014 Kieffer JM, Djajadiningrat RS, van Muilekom EA, Graafland NM, Horenblas S, Aaronson NK. Quality of life for patients treated for penile cancer. The Journal of Urology. 192: 1105-10. PMID 24747092 DOI: 10.1016/J.Juro.2014.04.014  0.416
2014 Blazeby JM, Hall E, Aaronson NK, Lloyd L, Waters R, Kelly JD, Fayers P. Validation and reliability testing of the EORTC QLQ-NMIBC24 questionnaire module to assess patient-reported outcomes in non-muscle-invasive bladder cancer. European Urology. 66: 1148-56. PMID 24612661 DOI: 10.1016/J.Eururo.2014.02.034  0.357
2014 Verdonck-de Leeuw IM, Buffart LM, Heymans MW, Rietveld DH, Doornaert P, de Bree R, Buter J, Aaronson NK, Slotman BJ, Leemans CR, Langendijk JA. The course of health-related quality of life in head and neck cancer patients treated with chemoradiation: a prospective cohort study. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 110: 422-8. PMID 24582144 DOI: 10.1016/J.Radonc.2014.01.002  0.449
2014 Eijzenga W, Bleiker EM, Hahn DE, Kluijt I, Sidharta GN, Gundy C, Aaronson NK. Psychosocial aspects of hereditary cancer (PAHC) questionnaire: development and testing of a screening questionnaire for use in clinical cancer genetics. Psycho-Oncology. 23: 862-9. PMID 24443031 DOI: 10.1002/Pon.3485  0.365
2014 Eijzenga W, Aaronson NK, Kluijt I, Sidharta GN, Hahn DE, Ausems MG, Bleiker EM. The efficacy of a standardized questionnaire in facilitating personalized communication about problems encountered in cancer genetic counseling: design of a randomized controlled trial. Bmc Cancer. 14: 26. PMID 24428912 DOI: 10.1186/1471-2407-14-26  0.324
2014 Wevers MR, Aaronson NK, Verhoef S, Bleiker EM, Hahn DE, Kuenen MA, van der Sanden-Melis J, Brouwer T, Hogervorst FB, van der Luijt RB, Valdimarsdottir HB, van Dalen T, Theunissen EB, van Ooijen B, de Roos MA, et al. Impact of rapid genetic counselling and testing on the decision to undergo immediate or delayed prophylactic mastectomy in newly diagnosed breast cancer patients: findings from a randomised controlled trial. British Journal of Cancer. 110: 1081-7. PMID 24423928 DOI: 10.1038/Bjc.2013.805  0.352
2014 Dirven L, Aaronson NK, Heimans JJ, Taphoorn MJ. Health-related quality of life in high-grade glioma patients. Chinese Journal of Cancer. 33: 40-5. PMID 24384239 DOI: 10.5732/Cjc.013.10214  0.441
2014 Efficace F, Rosti G, Aaronson N, Cottone F, Angelucci E, Molica S, Vignetti M, Mandelli F, Baccarani M. Patient- versus physician-reporting of symptoms and health status in chronic myeloid leukemia Haematologica. 99: 788-793. PMID 24241488 DOI: 10.3324/Haematol.2013.093724  0.331
2014 Gamper EM, Groenvold M, Petersen MA, Young T, Costantini A, Aaronson N, Giesinger JM, Meraner V, Kemmler G, Holzner B. The EORTC emotional functioning computerized adaptive test: phases I-III of a cross-cultural item bank development. Psycho-Oncology. 23: 397-403. PMID 24217943 DOI: 10.1002/Pon.3427  0.382
2014 Eijzenga W, Hahn DE, Aaronson NK, Kluijt I, Bleiker EM. Specific psychosocial issues of individuals undergoing genetic counseling for cancer - a literature review. Journal of Genetic Counseling. 23: 133-46. PMID 23996531 DOI: 10.1007/S10897-013-9649-4  0.354
2014 Victorson DE, Brucker PS, Bode RK, Eton DT, Talcott JA, Clark JA, Knight SJ, Litwin MS, Moinpour CM, Reeve BB, Aaronson NK, Bennett CL, Herr HW, McGuire M, Shevrin D, et al. Ensuring comprehensive assessment of urinary problems in prostate cancer through patient-physician concordance. Urologic Oncology. 32: 26.e25-31. PMID 23522840 DOI: 10.1016/J.Urolonc.2012.09.006  0.335
2014 Gehring K, Stuiver M, Rutten G, Taphoorn M, Aaronson N, Sitskoorn M. RH-02 * A PILOT RCT ON THE EFFICACY OF HOME-BASED EXERCISE TO IMPROVE COGNITIVE FUNCTIONING IN GRADE II AND III GLIOMA PATIENTS Neuro-Oncology. 16: v185-v185. DOI: 10.1093/Neuonc/Nou272.2  0.349
2014 Boele FW, Klein M, Armstrong TS, Reijneveld JC, Postma TJ, Taphoorn MJB, Aaronson NK, Heimans JJ, Sherwood PR. O9.02 * NEEDS OF INFORMAL CAREGIVERS OF PRIMARY MALIGNANT BRAIN TUMOR PATIENTS IN THE UNITED STATES AND THE NETHERLANDS: AN INTERNATIONAL COMPARISON Neuro-Oncology. 16: ii20-ii20. DOI: 10.1093/Neuonc/Nou174.73  0.328
2014 Dirven L, Meijer W, Sikkes SAM, Reijneveld JC, Aaronson NK, Uitdehaag BMJ, Taphoorn MJB. P15.04 * DEVELOPMENT OF A NEW QUESTIONNAIRE TO MEASURE INSTRUMENTAL ACTIVITIES OF DAILY LIVING (I-ADL) IN PATIENTS WITH PRIMARY BRAIN TUMOURS: RESULTS OF PHASE 1 Neuro-Oncology. 16: ii74-ii74. DOI: 10.1093/Neuonc/Nou174.283  0.341
2014 Boele FW, Douw L, Reijneveld JC, Robben R, Taphoorn MJB, Aaronson NK, Heimans JJ, Klein M. P15.02 * HEALTH-RELATED QUALITY OF LIFE IN STABLE, LONG-TERM LOW-GRADE GLIOMA SURVIVORS Neuro-Oncology. 16: ii73-ii74. DOI: 10.1093/Neuonc/Nou174.281  0.392
2013 Alonso J, Bartlett SJ, Rose M, Aaronson NK, Chaplin JE, Efficace F, Leplège A, Lu A, Tulsky DS, Raat H, Ravens-Sieberer U, Revicki D, Terwee CB, Valderas JM, Cella D, et al. The case for an international patient-reported outcomes measurement information system (PROMIS®) initiative. Health and Quality of Life Outcomes. 11: 210. PMID 24359143 DOI: 10.1186/1477-7525-11-210  0.348
2013 Buffart LM, Kalter J, Chinapaw MJ, Heymans MW, Aaronson NK, Courneya KS, Jacobsen PB, Newton RU, Verdonck-de Leeuw IM, Brug J. Predicting OptimaL cAncer RehabIlitation and Supportive care (POLARIS): rationale and design for meta-analyses of individual patient data of randomized controlled trials that evaluate the effect of physical activity and psychosocial interventions on health-related quality of life in cancer survivors. Systematic Reviews. 2: 75. PMID 24034173 DOI: 10.1186/2046-4053-2-75  0.413
2013 Boele FW, Heimans JJ, Aaronson NK, Taphoorn MJ, Postma TJ, Reijneveld JC, Klein M. Health-related quality of life of significant others of patients with malignant CNS versus non-CNS tumors: a comparative study. Journal of Neuro-Oncology. 115: 87-94. PMID 23824535 DOI: 10.1007/S11060-013-1198-Z  0.394
2013 Retèl VP, Groothuis-Oudshoorn CG, Aaronson NK, Brewer NT, Rutgers EJ, van Harten WH. Association between genomic recurrence risk and well-being among breast cancer patients. Bmc Cancer. 13: 295. PMID 23777535 DOI: 10.1186/1471-2407-13-295  0.35
2013 Dirven L, Reijneveld JC, Aaronson NK, Bottomley A, Uitdehaag BM, Taphoorn MJ. Health-related quality of life in patients with brain tumors: limitations and additional outcome measures. Current Neurology and Neuroscience Reports. 13: 359. PMID 23666388 DOI: 10.1007/S11910-013-0359-Y  0.383
2013 Lavoie Smith EM, Barton DL, Qin R, Steen PD, Aaronson NK, Loprinzi CL. Assessing patient-reported peripheral neuropathy: the reliability and validity of the European Organization for Research and Treatment of Cancer QLQ-CIPN20 Questionnaire. Quality of Life Research : An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation. 22: 2787-99. PMID 23543373 DOI: 10.1007/S11136-013-0379-8  0.397
2013 Kuijpers W, Groen WG, Aaronson NK, van Harten WH. A systematic review of web-based interventions for patient empowerment and physical activity in chronic diseases: relevance for cancer survivors. Journal of Medical Internet Research. 15: e37. PMID 23425685 DOI: 10.2196/Jmir.2281  0.343
2013 Petersen MA, Aaronson NK, Arraras JI, Chie WC, Conroy T, Costantini A, Giesinger JM, Holzner B, King MT, Singer S, Velikova G, Verdonck-de Leeuw IM, Young T, Groenvold M. The EORTC computer-adaptive tests measuring physical functioning and fatigue exhibited high levels of measurement precision and efficiency. Journal of Clinical Epidemiology. 66: 330-9. PMID 23347855 DOI: 10.1016/J.Jclinepi.2012.09.010  0.409
2013 Oskam IM, Verdonck-de Leeuw IM, Aaronson NK, Witte BI, de Bree R, Doornaert P, Langendijk JA, Leemans CR. Prospective evaluation of health-related quality of life in long-term oral and oropharyngeal cancer survivors and the perceived need for supportive care. Oral Oncology. 49: 443-8. PMID 23318122 DOI: 10.1016/J.Oraloncology.2012.12.005  0.402
2013 Reeve BB, Wyrwich KW, Wu AW, Velikova G, Terwee CB, Snyder CF, Schwartz C, Revicki DA, Moinpour CM, McLeod LD, Lyons JC, Lenderking WR, Hinds PS, Hays RD, Greenhalgh J, ... ... Aaronson NK, et al. ISOQOL recommends minimum standards for patient-reported outcome measures used in patient-centered outcomes and comparative effectiveness research. Quality of Life Research : An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation. 22: 1889-905. PMID 23288613 DOI: 10.1007/S11136-012-0344-Y  0.369
2013 Scott NW, Etta JA, Aaronson NK, Bottomley A, Fayers PM, Groenvold M, Koller M, KuliÅ› D, Marais D, Petersen MA, Sprangers MA. An evaluation of the response category translations of the EORTC QLQ-C30 questionnaire. Quality of Life Research : An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation. 22: 1483-90. PMID 23054491 DOI: 10.1007/S11136-012-0276-6  0.345
2013 Holzner B, Efficace F, Basso U, Johnson CD, Aaronson NK, Arraras JI, Smith AB, Chow E, Oberguggenberger AS, Bottomley A, Steiner H, Incrocci L, Giesinger JM. Cross-cultural development of an EORTC questionnaire to assess health-related quality of life in patients with testicular cancer: the EORTC QLQ-TC26. Quality of Life Research : An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation. 22: 369-78. PMID 22407356 DOI: 10.1007/S11136-012-0147-1  0.473
2013 Douma KF, Vasen HF, Aaronson NK, Bleiker EM. Reproductive decision-making in hereditary colorectal cancer: the role of the gastroenterologist Colorectal Cancer. 2: 13-16. DOI: 10.2217/Crc.12.77  0.309
2013 Kuijpers W, Groen WG, Oldenburg HSA, Wouters MWJM, Aaronson NK, Harten WHv. An interactive web portal for patient empowerment in cancer survivorship European Journal of Cancer. 49. DOI: 10.1016/S0959-8049(13)70061-3  0.355
2013 Mewes JC, Steuten LMG, Duijts SFA, Oldenburg HSS, Beurden vMFB, Stuiver MM, Hunter MS, Kieffer JM, Harten vWH, Aaronson NK. PCN77 – Cost-Effectiveness Of Cognitive-Behavioral Therapy And Physical Exercise For Alleviating Treatment-Induced Menopausal Symptoms In Breast Cancer Patients Value in Health. 16. DOI: 10.1016/J.Jval.2013.03.691  0.379
2012 Duijts SF, van Beurden M, Oldenburg HS, Hunter MS, Kieffer JM, Stuiver MM, Gerritsma MA, Menke-Pluymers MB, Plaisier PW, Rijna H, Lopes Cardozo AM, Timmers G, van der Meij S, van der Veen H, Bijker N, ... ... Aaronson NK, et al. Efficacy of cognitive behavioral therapy and physical exercise in alleviating treatment-induced menopausal symptoms in patients with breast cancer: results of a randomized, controlled, multicenter trial. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 4124-33. PMID 23045575 DOI: 10.1200/Jco.2012.41.8525  0.399
2012 Lagerwaard FJ, Aaronson NK, Gundy CM, Haasbeek CJ, Slotman BJ, Senan S. Patient-reported quality of life after stereotactic ablative radiotherapy for early-stage lung cancer. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 7: 1148-54. PMID 22610256 DOI: 10.1097/Jto.0B013E318252Cfef  0.428
2012 Khoshnevisan A, Yekaninejad MS, Ardakani SK, Pakpour AH, Mardani A, Aaronson NK. Translation and validation of the EORTC brain cancer module (EORTC QLQ-BN20) for use in Iran. Health and Quality of Life Outcomes. 10: 54. PMID 22607028 DOI: 10.1186/1477-7525-10-54  0.396
2012 Wevers MR, Hahn DE, Verhoef S, Bolhaar MD, Ausems MG, Aaronson NK, Bleiker EM. Breast cancer genetic counseling after diagnosis but before treatment: a pilot study on treatment consequences and psychological impact. Patient Education and Counseling. 89: 89-95. PMID 22543000 DOI: 10.1016/J.Pec.2012.03.019  0.341
2012 Gundy CM, Fayers PM, Groenvold M, Petersen MA, Scott NW, Sprangers MA, Velikova G, Aaronson NK. Comparing higher order models for the EORTC QLQ-C30. Quality of Life Research : An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation. 21: 1607-17. PMID 22187352 DOI: 10.1007/S11136-011-0082-6  0.343
2012 Snyder CF, Aaronson NK, Choucair AK, Elliott TE, Greenhalgh J, Halyard MY, Hess R, Miller DM, Reeve BB, Santana M. Implementing patient-reported outcomes assessment in clinical practice: a review of the options and considerations. Quality of Life Research : An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation. 21: 1305-14. PMID 22048932 DOI: 10.1007/S11136-011-0054-X  0.371
2012 Black N, Aaronson N. Donna Lamping (1953-2011). Quality of Life Research : An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation. 20: 1755-6. PMID 22038395 DOI: 10.1007/S11136-011-0047-9  0.364
2012 Chinapaw MJ, Buffart LM, van Mechelen W, Schep G, Aaronson NK, van Harten WH, Stuiver MM, Kersten MJ, Nollet F, Kaspers GJ, van Dulmen-den Broeder E, Huisman J, Takken T, van Tulder M, Brug J. Alpe d'HuZes cancer rehabilitation (A-CaRe) research: four randomized controlled exercise trials and economic evaluations in cancer patients and survivors. International Journal of Behavioral Medicine. 19: 143-56. PMID 21556821 DOI: 10.1007/S12529-011-9158-5  0.434
2012 Hilarius DL, Kloeg PH, van der Wall E, van den Heuvel JJ, Gundy CM, Aaronson NK. Chemotherapy-induced nausea and vomiting in daily clinical practice: a community hospital-based study. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. 20: 107-17. PMID 21258948 DOI: 10.1007/S00520-010-1073-9  0.419
2012 Wevers, Ausems M, Bleiker E, Rutgers E, Witkamp A, Hahn D, Brouwer T, Kuenen M, Sanden-Melis Jvd, Luijt Rvd, Hogervorst F, Dalen Tv, Theunissen E, Ooijen Bv, Roos Md, ... ... Aaronson N, et al. Abstract P4-11-01: Rapid genetic counseling and testing in newly diagnosed breast cancer patients, findings from an RCT Cancer Research. 72. DOI: 10.1158/0008-5472.Sabcs12-P4-11-01  0.409
2012 Oldenburg HSA, Duijts SFA, Beurden Mv, Kieffer JM, Hunter MS, Aaronson NK. 199 Efficacy of Cognitive Behavioral Therapy and Physical Exercise in Alleviating Treatment-induced Menopausal Symptoms in Patients with Breast Cancer – Results of a Randomized Controlled Multi-center Trial European Journal of Cancer. 48. DOI: 10.1016/S0959-8049(12)70267-8  0.351
2012 King M, Costa D, Aaronson N, Brazier J, Cella D, Fayers P, Pallant J, Peacock S, Pickard A, Rowen D, Velikova G, Young T. PCN98 The Development of an Internationally-Valid Cancer-Specific Multi-Attribute Utility Instrument (MAUI) From the Eortc Core Health-Related Quality of Life (HRQOL) Questionnaire, QLQ-C30 Value in Health. 15: A225. DOI: 10.1016/J.Jval.2012.03.1215  0.437
2011 Aaronson NK, Sprangers MA. [Measuring quality of life in every oncological patient]. Nederlands Tijdschrift Voor Geneeskunde. 155: A3749. PMID 22085564  0.339
2011 Aaronson NK, Taphoorn MJ, Heimans JJ, Postma TJ, Gundy CM, Beute GN, Slotman BJ, Klein M. Compromised health-related quality of life in patients with low-grade glioma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 4430-5. PMID 22010018 DOI: 10.1200/Jco.2011.35.5750  0.4
2011 van de Poll-Franse LV, Horevoorts N, van Eenbergen M, Denollet J, Roukema JA, Aaronson NK, Vingerhoets A, Coebergh JW, de Vries J, Essink-Bot ML, Mols F. The Patient Reported Outcomes Following Initial treatment and Long term Evaluation of Survivorship registry: scope, rationale and design of an infrastructure for the study of physical and psychosocial outcomes in cancer survivorship cohorts. European Journal of Cancer (Oxford, England : 1990). 47: 2188-94. PMID 21621408 DOI: 10.1016/J.Ejca.2011.04.034  0.406
2011 Giesinger JM, Aa Petersen M, Groenvold M, Aaronson NK, Arraras JI, Conroy T, Gamper EM, Kemmler G, King MT, Oberguggenberger AS, Velikova G, Young T, Holzner B. Cross-cultural development of an item list for computer-adaptive testing of fatigue in oncological patients. Health and Quality of Life Outcomes. 9: 19. PMID 21447160 DOI: 10.1186/1477-7525-9-19  0.351
2011 Duijts SF, Stolk-Vos AC, Oldenburg HS, van Beurden M, Aaronson NK. Characteristics of breast cancer patients who experience menopausal transition due to treatment. Climacteric : the Journal of the International Menopause Society. 14: 362-8. PMID 21401440 DOI: 10.3109/13697137.2011.557163  0.372
2011 Snyder CF, Blackford AL, Aaronson NK, Detmar SB, Carducci MA, Brundage MD, Wu AW. Can patient-reported outcome measures identify cancer patients' most bothersome issues? Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 1216-20. PMID 21343558 DOI: 10.1200/Jco.2010.33.2080  0.423
2011 Terlou A, van Seters M, Ewing PC, Aaronson NK, Gundy CM, Heijmans-Antonissen C, Quint WG, Blok LJ, van Beurden M, Helmerhorst TJ. Treatment of vulvar intraepithelial neoplasia with topical imiquimod: seven years median follow-up of a randomized clinical trial. Gynecologic Oncology. 121: 157-62. PMID 21239049 DOI: 10.1016/J.Ygyno.2010.12.340  0.31
2011 Wevers MR, Ausems MG, Verhoef S, Bleiker EM, Hahn DE, Hogervorst FB, van der Luijt RB, Valdimarsdottir HB, van Hillegersberg R, Rutgers EJ, Aaronson NK. Behavioral and psychosocial effects of rapid genetic counseling and testing in newly diagnosed breast cancer patients: design of a multicenter randomized clinical trial. Bmc Cancer. 11: 6. PMID 21219598 DOI: 10.1186/1471-2407-11-6  0.343
2011 Gehring K, Aaronson NK, Gundy CM, Taphoorn MJ, Sitskoorn MM. Predictors of neuropsychological improvement following cognitive rehabilitation in patients with gliomas. Journal of the International Neuropsychological Society : Jins. 17: 256-66. PMID 21205412 DOI: 10.1017/S1355617710001530  0.311
2011 van de Poll-Franse LV, Mols F, Gundy CM, Creutzberg CL, Nout RA, Verdonck-de Leeuw IM, Taphoorn MJ, Aaronson NK. Normative data for the EORTC QLQ-C30 and EORTC-sexuality items in the general Dutch population. European Journal of Cancer (Oxford, England : 1990). 47: 667-75. PMID 21134739 DOI: 10.1016/J.Ejca.2010.11.004  0.31
2011 Knols RH, de Bruin ED, Uebelhart D, Aufdemkampe G, Schanz U, Stenner-Liewen F, Hitz F, Taverna C, Aaronson NK. Effects of an outpatient physical exercise program on hematopoietic stem-cell transplantation recipients: a randomized clinical trial. Bone Marrow Transplantation. 46: 1245-55. PMID 21132025 DOI: 10.1038/Bmt.2010.288  0.339
2011 Petersen MA, Groenvold M, Aaronson NK, Chie WC, Conroy T, Costantini A, Fayers P, Helbostad J, Holzner B, Kaasa S, Singer S, Velikova G, Young T. Development of computerized adaptive testing (CAT) for the EORTC QLQ-C30 physical functioning dimension. Quality of Life Research : An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation. 20: 479-90. PMID 20972628 DOI: 10.1007/S11136-010-9770-X  0.376
2011 Douma KF, Bleiker EM, Vasen HF, Gundy CM, Aaronson NK. Quality of life and consequences for daily life of familial adenomatous polyposis (FAP) family members. Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland. 13: 669-77. PMID 20402739 DOI: 10.1111/J.1463-1318.2010.02275.X  0.372
2011 Duijts SF, Faber MM, Oldenburg HS, van Beurden M, Aaronson NK. Effectiveness of behavioral techniques and physical exercise on psychosocial functioning and health-related quality of life in breast cancer patients and survivors--a meta-analysis. Psycho-Oncology. 20: 115-26. PMID 20336645 DOI: 10.1002/Pon.1728  0.427
2011 Hilarius DL, Kloeg PH, van der Wall E, Komen M, Gundy CM, Aaronson NK. Cancer-related fatigue: clinical practice versus practice guidelines. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. 19: 531-8. PMID 20238129 DOI: 10.1007/S00520-010-0848-3  0.362
2011 Douma KF, Bleiker EM, Vasen HF, Gundy CM, Gerritsma MA, Aaronson NK. Psychological distress and quality of life of partners of individuals with familial adenomatous polyposis. Psycho-Oncology. 20: 146-54. PMID 20198719 DOI: 10.1002/Pon.1716  0.406
2011 Aaronson NK, Sprangers MAG. Measuring quality of life in every cancer patient | Kwaliteit van leven meten bij elke oncologiepatiënt Nederlands Tijdschrift Voor Geneeskunde. 155: 2004-2006.  0.353
2010 Gehring K, Aaronson NK, Taphoorn MJ, Sitskoorn MM. Interventions for cognitive deficits in patients with a brain tumor: an update. Expert Review of Anticancer Therapy. 10: 1779-95. PMID 21080804 DOI: 10.1586/Era.10.163  0.308
2010 Kaptein AA, Yamaoka K, Snoei L, Kobayashi K, Uchida Y, van der Kloot WA, Tabei T, Kleijn WC, Koster M, Wijnands G, Kaajan H, Tran T, Inoue K, van Klink R, van Dooren-Coppens E, ... ... Aaronson N, et al. Illness perceptions and quality of life in Japanese and Dutch patients with non-small-cell lung cancer. Lung Cancer (Amsterdam, Netherlands). 72: 384-90. PMID 20947200 DOI: 10.1016/J.Lungcan.2010.09.010  0.442
2010 Knols RH, de Bruin ED, Shirato K, Uebelhart D, Aaronson NK. Physical activity interventions to improve daily walking activity in cancer survivors. Bmc Cancer. 10: 406. PMID 20684789 DOI: 10.1186/1471-2407-10-406  0.349
2010 Scott NW, Fayers PM, Aaronson NK, Bottomley A, de Graeff A, Groenvold M, Gundy C, Koller M, Petersen MA, Sprangers MA. Differential item functioning (DIF) analyses of health-related quality of life instruments using logistic regression. Health and Quality of Life Outcomes. 8: 81. PMID 20684767 DOI: 10.1186/1477-7525-8-81  0.385
2010 Lammens CR, Bleiker EM, Aaronson NK, Wagner A, Sijmons RH, Ausems MG, Vriends AH, Ruijs MW, van Os TA, Spruijt L, Gómez García EB, Cats A, Nagtegaal T, Verhoef S. Regular surveillance for Li-Fraumeni Syndrome: advice, adherence and perceived benefits. Familial Cancer. 9: 647-54. PMID 20658357 DOI: 10.1007/S10689-010-9368-Z  0.34
2010 Courrech Staal EF, van Sandick JW, van Tinteren H, Cats A, Aaronson NK. Health-related quality of life in long-term esophageal cancer survivors after potentially curative treatment. The Journal of Thoracic and Cardiovascular Surgery. 140: 777-83. PMID 20554296 DOI: 10.1016/J.Jtcvs.2010.05.018  0.443
2010 Scott NW, Fayers PM, Aaronson NK, Bottomley A, de Graeff A, Groenvold M, Gundy C, Koller M, Petersen MA, Sprangers MA. Interpretation of differential item functioning analyses using external review. Expert Review of Pharmacoeconomics & Outcomes Research. 10: 253-8. PMID 20545590 DOI: 10.1586/Erp.10.22  0.339
2010 Knols RH, de Bruin ED, Uebelhart D, Aaronson NK. The relationship between ambulatory step activity, self-reported physical functioning and standardised timed walking in patients with haematological malignancies. Disability and Rehabilitation. 32: 1819-26. PMID 20337514 DOI: 10.3109/09638281003734482  0.325
2010 Petersen MA, Groenvold M, Aaronson NK, Chie WC, Conroy T, Costantini A, Fayers P, Helbostad J, Holzner B, Kaasa S, Singer S, Velikova G, Young T. Development of computerised adaptive testing (CAT) for the EORTC QLQ-C30 dimensions - general approach and initial results for physical functioning. European Journal of Cancer (Oxford, England : 1990). 46: 1352-8. PMID 20231085 DOI: 10.1016/J.Ejca.2010.02.011  0.411
2010 Oskam IM, Verdonck-de Leeuw IM, Aaronson NK, Kuik DJ, de Bree R, Doornaert P, Langendijk JA, Leemans CR. Quality of life as predictor of survival: a prospective study on patients treated with combined surgery and radiotherapy for advanced oral and oropharyngeal cancer. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 97: 258-62. PMID 20189668 DOI: 10.1016/J.Radonc.2010.02.005  0.434
2010 Taphoorn MJ, Claassens L, Aaronson NK, Coens C, Mauer M, Osoba D, Stupp R, Mirimanoff RO, van den Bent MJ, Bottomley A. An international validation study of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing health-related quality of life and symptoms in brain cancer patients. European Journal of Cancer (Oxford, England : 1990). 46: 1033-40. PMID 20181476 DOI: 10.1016/J.Ejca.2010.01.012  0.435
2010 Vachalec S, Bottomley A, Aaronson N, Van Andel G, Blazeby J. Confusion about European Organisation for Research and Treatment of Cancer Quality of Life Prostate module (EORTC QLQ-PR25): a response. Expert Review of Pharmacoeconomics & Outcomes Research. 2: 6. PMID 19807423 DOI: 10.1586/14737167.2.1.6  0.39
2010 Douma KF, Aaronson NK, Vasen HF, Gerritsma MA, Gundy CM, Janssen EP, Vriends AH, Cats A, Verhoef S, Bleiker EM. Psychological distress and use of psychosocial support in familial adenomatous polyposis. Psycho-Oncology. 19: 289-98. PMID 19382100 DOI: 10.1002/Pon.1570  0.324
2010 Senan S, Gundy C, Haasbeek CJ, Slotman BJ, Aaronson NK, Lagerwaard FJ. Health-related quality of life (HRQOL) after stereotactic body radiotherapy (SBRT) for stage I non-small cell lung cancer (NSCLC). Journal of Clinical Oncology. 28: 7079-7079. DOI: 10.1200/Jco.2010.28.15_Suppl.7079  0.373
2010 Duijts S, Oldenburg H, van Beurden M, Aaronson N. 515 Cognitive behavioral therapy and physical exercise for climacteric symptoms in breast cancer patients experiencing treatment-induced menopause European Journal of Cancer Supplements. 8: 210. DOI: 10.1016/S1359-6349(10)70536-X  0.339
2009 Douw L, Klein M, Fagel SS, van den Heuvel J, Taphoorn MJ, Aaronson NK, Postma TJ, Vandertop WP, Mooij JJ, Boerman RH, Beute GN, Sluimer JD, Slotman BJ, Reijneveld JC, Heimans JJ. Cognitive and radiological effects of radiotherapy in patients with low-grade glioma: long-term follow-up. The Lancet. Neurology. 8: 810-8. PMID 19665931 DOI: 10.1016/S1474-4422(09)70204-2  0.309
2009 Scott NW, Fayers PM, Aaronson NK, Bottomley A, de Graeff A, Groenvold M, Gundy C, Koller M, Petersen MA, Sprangers MA. The practical impact of differential item functioning analyses in a health-related quality of life instrument. Quality of Life Research : An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation. 18: 1125-30. PMID 19653125 DOI: 10.1007/S11136-009-9521-Z  0.392
2009 Lammens C, Bleiker E, Aaronson N, Vriends A, Ausems M, Jansweijer M, Wagner A, Sijmons R, van den Ouweland A, van der Luijt R, Spruijt L, Gómez García E, Ruijs M, Verhoef S. Attitude towards pre-implantation genetic diagnosis for hereditary cancer. Familial Cancer. 8: 457-64. PMID 19642022 DOI: 10.1007/S10689-009-9265-5  0.302
2009 Duijts SF, Oldenburg HS, van Beurden M, Aaronson NK. Cognitive behavioral therapy and physical exercise for climacteric symptoms in breast cancer patients experiencing treatment-induced menopause: design of a multicenter trial. Bmc Women's Health. 9: 15. PMID 19500403 DOI: 10.1186/1472-6874-9-15  0.338
2009 Gehring K, Sitskoorn MM, Gundy CM, Sikkes SA, Klein M, Postma TJ, van den Bent MJ, Beute GN, Enting RH, Kappelle AC, Boogerd W, Veninga T, Twijnstra A, Boerman DH, Taphoorn MJ, ... Aaronson NK, et al. Cognitive rehabilitation in patients with gliomas: a randomized, controlled trial. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 3712-22. PMID 19470928 DOI: 10.1200/Jco.2008.20.5765  0.315
2009 Rinkel RN, Verdonck-de Leeuw IM, Langendijk JA, van Reij EJ, Aaronson NK, Leemans CR. The psychometric and clinical validity of the SWAL-QOL questionnaire in evaluating swallowing problems experienced by patients with oral and oropharyngeal cancer. Oral Oncology. 45: e67-71. PMID 19442567 DOI: 10.1016/J.Oraloncology.2009.03.003  0.442
2009 Pickard AS, Shaw JW, Lin HW, Trask PC, Aaronson N, Lee TA, Cella D. A patient-based utility measure of health for clinical trials of cancer therapy based on the European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 12: 977-88. PMID 19402850 DOI: 10.1111/J.1524-4733.2009.00545.X  0.426
2009 Scott NW, Fayers PM, Aaronson NK, Bottomley A, De Graeff A, Groenvold M, Gundy C, Koller M, Petersen MA, Sprangers MAG, King M, Leutenegger S, Spry N, Greimel E, Holzner B, ... ... Aaronson N, et al. Differential item functioning (DIF) in the EORTC QLQ-C30: A comparison of baseline, on-treatment and off-treatment data Quality of Life Research. 18: 381-388. PMID 19247808 DOI: 10.1007/S11136-009-9453-7  0.396
2009 Vermeulen E, Schmidt MK, Aaronson NK, Kuenen M, van Leeuwen FE. Obtaining 'fresh' consent for genetic research with biological samples archived 10 years ago. European Journal of Cancer (Oxford, England : 1990). 45: 1168-74. PMID 19232486 DOI: 10.1016/J.Ejca.2008.11.022  0.308
2009 Knols RH, de Bruin ED, Aufdemkampe G, Uebelhart D, Aaronson NK. Reliability of ambulatory walking activity in patients with hematologic malignancies. Archives of Physical Medicine and Rehabilitation. 90: 58-65. PMID 19154830 DOI: 10.1016/J.Apmr.2008.06.020  0.36
2009 Jayasekara H, Rajapaksa LC, Aaronson NK. Health-related quality-of-life in patients with head-and-neck cancer in Sri Lanka: psychometric properties of the 'Sinhala' version of the EORTC QLQ-H&N35. Psycho-Oncology. 18: 1116-21. PMID 19142857 DOI: 10.1002/Pon.1430  0.432
2009 Vermeulen E, Schmidt MK, Aaronson NK, Kuenen M, Van Der Valk P, Sietses C, Van Den Tol P, Van Leeuwen FE. Opt-out plus, the patients' choice: Preferences of cancer patients concerning information and consent regimen for future research with biological samples archived in the context of treatment Journal of Clinical Pathology. 62: 275-278. PMID 19017681 DOI: 10.1136/Jcp.2008.061069  0.335
2009 Hoopman R, Terwee CB, Muller MJ, Öry FG, Aaronson NK. Methodological challenges in quality of life research among Turkish and Moroccan ethnic minority cancer patients: Translation, recruitment and ethical issues Ethnicity and Health. 14: 237-253. PMID 19012066 DOI: 10.1080/13557850802398832  0.453
2009 Scott NW, Fayers PM, Aaronson NK, Bottomley A, de Graeff A, Groenvold M, Gundy C, Koller M, Petersen MA, Sprangers MAG. A simulation study provided sample size guidance for differential item functioning (DIF) studies using short scales Journal of Clinical Epidemiology. 62: 288-295. PMID 18774693 DOI: 10.1016/J.Jclinepi.2008.06.003  0.337
2009 Bosma I, Reijneveld JC, Douw L, Vos MJ, Postma TJ, Aaronson NK, Muller M, Vandertop WP, Slotman BJ, Taphoorn MJ, Heimans JJ, Klein M. Health-related quality of life of long-term high-grade glioma survivors. Neuro-Oncology. 11: 51-8. PMID 18617599 DOI: 10.1215/15228517-2008-049  0.363
2008 Pickard AS, Shaw JW, Lin H, Trask PC, Aaronson NK, Lee TA, Cella D. A patient-based utility measure of health for clinical trials of cancer therapy. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 6529. PMID 27949945 DOI: 10.1200/Jco.2008.26.15_Suppl.6529  0.462
2008 Aaronson NK, Snyder C. Using patient-reported outcomes in clinical practice: proceedings of an International Society of Quality of Life Research conference. Quality of Life Research : An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation. 17: 1295. PMID 19048409 DOI: 10.1007/S11136-008-9422-6  0.375
2008 van Andel G, Bottomley A, Fosså SD, Efficace F, Coens C, Guerif S, Kynaston H, Gontero P, Thalmann G, Akdas A, D'Haese S, Aaronson NK. An international field study of the EORTC QLQ-PR25: A questionnaire for assessing the health-related quality of life of patients with prostate cancer European Journal of Cancer. 44: 2418-2424. PMID 18774706 DOI: 10.1016/J.Ejca.2008.07.030  0.445
2008 Langendijk JA, Doornaert P, Verdonck-de Leeuw IM, Leemans CR, Aaronson NK, Slotman BJ. Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy Journal of Clinical Oncology. 26: 3770-3776. PMID 18669465 DOI: 10.1200/Jco.2007.14.6647  0.407
2008 Hilarius DL, Kloeg PH, Gundy CM, Aaronson NK. Use of health-related quality-of-life assessments in daily clinical oncology nursing practice: A community hospital-based intervention study Cancer. 113: 628-637. PMID 18543317 DOI: 10.1002/Cncr.23623  0.388
2008 Hoopman R, Terwee CB, Aaronson NK. Translated COOP/WONCA charts found appropriate for use among Turkish and Moroccan ethnic minority cancer patients Journal of Clinical Epidemiology. 61: 1036-1048. PMID 18539431 DOI: 10.1016/J.Jclinepi.2007.11.018  0.395
2008 Mols F, Aquarius AE, Essink-Bot ML, Aaronson NK, Kil PJM, Van De Poll-Franse LV. Does diabetes mellitus as a comorbid condition affect the health-related quality of life in prostate cancer survivors? Results of a population-based observational study Bju International. 102: 1594-1600. PMID 18522628 DOI: 10.1111/J.1464-410X.2008.07812.X  0.39
2008 Gehring K, Sitskoorn MM, Aaronson NK, Taphoorn MJ. Interventions for cognitive deficits in adults with brain tumours The Lancet Neurology. 7: 548-560. PMID 18485318 DOI: 10.1016/S1474-4422(08)70111-X  0.302
2008 Jayasekara H, Rajapaksa LC, Aaronson NK. Quality of life in cancer patients in South Asia: Psychometric properties of the Sinhala version of the EORTC QLQ-C30 in cancer patients with heterogeneous diagnoses Quality of Life Research. 17: 783-791. PMID 18427948 DOI: 10.1007/S11136-008-9345-2  0.47
2008 Scott NW, Fayers PM, Aaronson NK, Bottomley A, de Graeff A, Groenvold M, Koller M, Petersen MA, Sprangers MAG. The relationship between overall quality of life and its subdimensions was influenced by culture: analysis of an international database Journal of Clinical Epidemiology. 61: 788-795. PMID 18359194 DOI: 10.1016/J.Jclinepi.2007.08.015  0.404
2008 Rinkel RN, Verdonck-de Leeuw IM, Van Reij EJ, Aaronson NK, Leemans R. Speech handicap index in patients with oral and pharyngeal cancer: Better understanding of patients' complaints Head and Neck. 30: 868-874. PMID 18302270 DOI: 10.1002/Hed.20795  0.353
2008 Gundy CM, Aaronson NK. The influence of proxy perspective on patient-proxy agreement in the evaluation of health-related quality of life: An empirical study Medical Care. 46: 209-216. PMID 18219250 DOI: 10.1097/Mlr.0B013E318158Af13  0.41
2008 Acquadro C, Conway K, Hareendran A, Aaronson N. Literature review of methods to translate health-related quality of life questionnaires for use in multinational clinical trials. Value in Health. 11: 509-521. PMID 18179659 DOI: 10.1111/J.1524-4733.2007.00292.X  0.344
2008 Taphoorn MJ, Claassens L, Aaronson NK, Coens C, Mauer M, Osoba D, Stupp R, Mirimanoff R, Van den Bent MJ, Bottomley A. The EORTC QLQ-BN20 questionnaire for assessing the health-related quality of life (HRQoL) in brain cancer patients: A phase IV validation study on behalf of the EORTC QLG, BCG, ROG, NCIC-CTG Journal of Clinical Oncology. 26: 2041-2041. DOI: 10.1200/Jco.2008.26.15_Suppl.2041  0.421
2007 Buijs C, Rodenhuis S, Seynaeve CM, Van Hoesel QGCM, Van Der Wall E, Smit WJM, Nooij MA, Voest E, Hupperets P, TenVergert EM, Van Tinteren H, Willemse PHB, Mourits MJE, Aaronson NK, Post WJ, et al. Prospective study of long-term impact of adjuvant high-dose and conventional-dose chemotherapy on health-related quality of life Journal of Clinical Oncology. 25: 5403-5409. PMID 18048822 DOI: 10.1200/Jco.2007.11.2813  0.392
2007 Bottomley A, Aaronson NK. International perspective on health-related quality-of-life research in cancer clinical trials: The European Organisation for Research and Treatment of Cancer experience Journal of Clinical Oncology. 25: 5082-5086. PMID 17991925 DOI: 10.1200/Jco.2007.11.3183  0.43
2007 Koller M, Aaronson NK, Blazeby J, Bottomley A, Dewolf L, Fayers P, Johnson C, Ramage J, Scott N, West K. Translation procedures for standardised quality of life questionnaires: The European Organisation for Research and Treatment of Cancer (EORTC) approach European Journal of Cancer. 43: 1810-1820. PMID 17689070 DOI: 10.1016/J.Ejca.2007.05.029  0.415
2007 Mols F, Aaronson NK, Vingerhoets AJJM, Coebergh JW, Vreugdenhil G, Lybeert MLM, Van De Poll-Franse LV. Quality of life among long-term non-hodgkin lymphoma survivors: A population-based study Cancer. 109: 1659-1667. PMID 17330853 DOI: 10.1002/Cncr.22581  0.346
2007 Borggreven PA, Aaronson NK, Verdonck-de Leeuw IM, Muller MJ, Heiligers MLCH, Bree Rd, Langendijk JA, Leemans CR. Quality of life after surgical treatment for oral and oropharyngeal cancer: A prospective longitudinal assessment of patients reconstructed by a microvascular flap Oral Oncology. 43: 1034-1042. PMID 17307019 DOI: 10.1016/J.Oraloncology.2006.11.017  0.45
2007 Noorda EM, van Kreij RHJ, Vrouenraets BC, Nieweg OE, Muller M, Kroon BBR, Aaronson NK. The health-related quality of life of long-term survivors of melanoma treated with isolated limb perfusion European Journal of Surgical Oncology. 33: 776-782. PMID 17300914 DOI: 10.1016/J.Ejso.2006.03.024  0.356
2007 Borggreven PA, Verdonck-De Leeuw IM, Muller MJ, Heiligers MLCH, De Bree R, Aaronson NK, Leemans CR. Quality of life and functional status in patients with cancer of the oral cavity and oropharynx: Pretreatment values of a prospective study European Archives of Oto-Rhino-Laryngology. 264: 651-657. PMID 17273840 DOI: 10.1007/S00405-007-0249-5  0.373
2007 Brédart A, Coens C, Aaronson N, Chie W-, Efficace F, Conroy T, Blazeby JM, Hammerlid E, Costantini M, Joly F, Schraub S, Sezer O, Arraras JI, Rodary C, Costantini A, et al. Determinants of patient satisfaction in oncology settings from European and Asian countries: Preliminary results based on the EORTC IN-PATSAT32 questionnaire European Journal of Cancer. 43: 323-330. PMID 17156997 DOI: 10.1016/J.Ejca.2006.10.016  0.421
2007 Scott NW, Fayers PM, Aaronson NK, Bottomley A, De Graeff A, Groenvold M, Koller M, Petersen MA, Sprangers MAG. The use of differential item functioning analyses to identify cultural differences in responses to the EORTC QLQ-C30 Quality of Life Research. 16: 115-129. PMID 17109190 DOI: 10.1007/S11136-006-9120-1  0.391
2007 Groenvold M, Fayers PM, Petersen MA, Sprangers MAG, Aaronson NK, Mouridsen HT. Breast cancer patients on adjuvant chemotherapy report a wide range of problems not identified by health-care staff Breast Cancer Research and Treatment. 103: 185-195. PMID 17039266 DOI: 10.1007/S10549-006-9365-Y  0.421
2007 Bosma I, Vos MJ, Heimans JJ, Taphoorn MJ, Aaronson NK, Postma TJ, van der Ploeg HM, Muller M, Vandertop WP, Slotman BJ, Klein M. The course of neurocognitive functioning in high-grade glioma patients. Neuro-Oncology. 9: 53-62. PMID 17018697 DOI: 10.1215/15228517-2006-012  0.33
2007 Hilarius DL, Kloeg PHAM, Detmar SB, Muller MJ, Aaronson NK. Level of agreement between patient self-report and observer ratings of health-related quality of life communication in oncology Patient Education and Counseling. 65: 95-100. PMID 16872790 DOI: 10.1016/J.Pec.2006.06.002  0.405
2007 Verdonck-de Leeuw I, Oskam I, Borggreven P, Aaronson N, Kuik J, de Breek R, Langendijk H, Leemans R. O104 Health related quality of life and survival: a prospective study in patients after with advanced oral and oropharyngeal cancer Oral Oncology Supplement. 2: 92. DOI: 10.1016/S1744-7895(07)70157-8  0.426
2006 Efficace F, Horneber M, Lejeune S, Van Dam F, Leering S, Rottmann M, Aaronson NK. Methodological quality of patient-reported outcome research was low in complementary and alternative medicine in oncology Journal of Clinical Epidemiology. 59: 1257.e1-1257.e14. PMID 17098568 DOI: 10.1016/J.Jclinepi.2006.03.006  0.361
2006 Mols F, Van De Poll-Franse LV, Vingerhoets AJJM, Hendrikx A, Aaronson NK, Houterman S, Coebergh JWW, Essink-Bot ML. Long-term quality of life among Dutch prostate cancer survivors: Results of a population-based study Cancer. 107: 2186-2196. PMID 17013914 DOI: 10.1002/Cncr.22231  0.389
2006 Hoopman R, Terwee CB, Muller MJ, Aaronson NK. Translation and validation of the SF-36 Health Survey for use among Turkish and Moroccan ethnic minority cancer patients in The Netherlands European Journal of Cancer. 42: 2982-2990. PMID 17011775 DOI: 10.1016/J.Ejca.2006.08.011  0.395
2006 Revicki DA, Cella D, Hays RD, Sloan JA, Lenderking WR, Aaronson NK. Responsiveness and minimal important differences for patient reported outcomes. Health and Quality of Life Outcomes. 4: 70. PMID 17005038 DOI: 10.1186/1477-7525-4-70  0.363
2006 Mols F, Vingerhoets AJJM, Coebergh JW, Vreugdenhil G, Aaronson NK, Lybeert MLM, van de Poll-Franse LV. Better quality of life among 10-15 year survivors of Hodgkin's lymphoma compared to 5-9 year survivors: A population-based study European Journal of Cancer. 42: 2794-2801. PMID 16996260 DOI: 10.1016/J.Ejca.2006.08.006  0.422
2006 Scott NW, Fayers PM, Bottomley A, Aaronson NK, De Graeff A, Groenvold M, Koller M, Petersen MA, Sprangers MAG. Comparing translations of the EORTC QLQ-C30 using differential item functioning analyses Quality of Life Research. 15: 1103-1115. PMID 16900290 DOI: 10.1007/S11136-006-0040-X  0.42
2006 Jellema AP, Slotman BJ, Muller MJ, Leemans CR, Smeele LE, Hoekman K, Aaronson NK, Langendijk JA. Radiotherapy alone, versus radiotherapy with amifostine 3 times weekly, versus radiotherapy with amifostine 5 times weekly: A prospective randomized study in squamous cell head and neck cancer Cancer. 107: 544-553. PMID 16804929 DOI: 10.1002/Cncr.22020  0.344
2006 Sloan JA, Frost MH, Berzon R, Dueck A, Guyatt G, Moinpour C, Sprangers M, Ferrans C, Cella D, Aaronson N, Barofsky I, Bonomi A, Bullinger M, Cappelleri J, Fairclough D, et al. The clinical significance of quality of life assessments in oncology: A summary for clinicians Supportive Care in Cancer. 14: 988-998. PMID 16794811 DOI: 10.1007/S00520-006-0085-Y  0.374
2006 Hoopman R, Muller MJ, Terwee CB, Aaronson NK. Translation and validation of the EORTC QLQ-C30 for use among Turkish and Moroccan ethnic minority cancer patients in the Netherlands European Journal of Cancer. 42: 1839-1847. PMID 16750911 DOI: 10.1016/J.Ejca.2005.08.047  0.43
2006 Groenvold M, Petersen MA, Aaronson NK, Arraras JI, Blazeby JM, Bottomley A, Fayers PM, de Graeff A, Hammerlid E, Kaasa S, Sprangers MA, Bjorner JB. EORTC QLQ-C15-PAL: the new standard in the assessment of health-related quality of life in advanced cancer? Palliative Medicine. 20: 59-61. PMID 16613400 DOI: 10.1191/0269216306pm1133xx  0.321
2006 Petersen MA, Groenvold M, Aaronson N, Fayers PM, Sprangers MAG, Bjorner JB. Multidimensional computerized adaptive testing of the EORTC QLQ-C30: basic developments and evaluations. Quality of Life Research. 15: 315-329. PMID 16547770 DOI: 10.1007/S11136-005-3214-Z  0.41
2006 van Luijn HEM, Aaronson NK, Keus RB, Musschenga AW. The evaluation of the risks and benefits of phase II cancer clinical trials by institutional review board (IRB) members: A case study Journal of Medical Ethics. 32: 170-176. PMID 16507666 DOI: 10.1136/Jme.2002.001503  0.333
2006 Groenvold M, Petersen MA, Aaronson NK, Arraras JI, Blazeby JM, Bottomley A, Fayers PM, De Graeff A, Hammerlid E, Kaasa S, Sprangers MAG, Bjorner JB. The development of the EORTC QLQ-C15-PAL: A shortened questionnaire for cancer patients in palliative care European Journal of Cancer. 42: 55-64. PMID 16162404 DOI: 10.1016/J.Ejca.2005.06.022  0.389
2006 Koller M, Aaronson NK, Blazeby J, Bottomley A, Johnson C, Ramage J, West K. The European Organisation for Research and Treatment of Cancer (EORTC) translation procedure for standardized quality of life questionnaires Journal of Clinical Oncology. 24: 16033-16033. DOI: 10.1200/Jco.2006.24.18_Suppl.16033  0.404
2006 Groenvold M, Petersen MA, Aaronson NK, Arraras JI, Blazeby JM, Bottomley A, Fayers PM, de Graeff A, Hanmerlid E, Kaasa S, Sprangers MAG, Bjorner JB. EORTC QLQ-C15-PAL: The new standard in the assessment of health-related quality of life in advanced cancer? [1] Palliative Medicine. 20: 51-61. DOI: 10.1191/026921636pm1133xx  0.321
2005 Bleiker E, Wigbout G, van Rens A, Verhoef S, Van't Veer L, Aaronson N. Withdrawal from genetic counselling for cancer. Hereditary Cancer in Clinical Practice. 3: 19-27. PMID 20223026 DOI: 10.1186/1897-4287-3-1-19  0.321
2005 Coens C, Bottomley A, Efficace F, Flechtner H, Aaronson N. Variability and Sample Size Requirements for Health-Related Quality-of-Life Measures: Understanding the Challenges Facing Investigators Journal of Clinical Oncology. 23: 8541-8542. PMID 16293886 DOI: 10.1200/Jco.2005.03.9776  0.342
2005 Brédart A, Bottomley A, Blazeby JM, Conroy T, Coens C, D'Haese S, Chie WC, Hammerlid E, Arraras JI, Efficace F, Rodary C, Schraub S, Costantini M, Costantini A, Joly F, ... ... Aaronson NK, et al. An international prospective study of the EORTC cancer in-patient satisfaction with care measure (EORTC IN-PATSAT32) European Journal of Cancer. 41: 2120-2131. PMID 16182120 DOI: 10.1016/J.Ejca.2005.04.041  0.379
2005 Madalinska JE, Hollenstein J, Bleiker E, Van Beurden M, Valdimarsdottir HB, Massuger LF, Gaarenstroom KN, Mourits MJE, Verheijen RHM, Van Dorst EBL, Van Der Putten H, Van Der Velden K, Boonstra H, Aaronson NK. Quality-of-life effects of prophylactic salpingo-oophorectomy versus gynecologic screening among women at increased risk of hereditary ovarian cancer Journal of Clinical Oncology. 23: 6890-6898. PMID 16129845 DOI: 10.1200/Jco.2005.02.626  0.383
2005 Petersen MA, Groenvold M, Aaronson N, Brenne E, Fayers P, Nielsen JD, Sprangers M, Bjorner JB. Scoring based on item response theory did not alter the measurement ability of EORTC QLQ-C30 scales Journal of Clinical Epidemiology. 58: 902-908. PMID 16085193 DOI: 10.1016/J.Jclinepi.2005.02.008  0.309
2005 Postma TJ, Aaronson NK, Heimans JJ, Muller MJ, Hildebrand JG, Delattre JY, Hoang-Xuan K, Lantéri-Minet M, Grant R, Huddart R, Moynihan C, Maher J, Lucey R. The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: the QLQ-CIPN20. European Journal of Cancer (Oxford, England : 1990). 41: 1135-9. PMID 15911236 DOI: 10.1016/J.Ejca.2005.02.012  0.453
2005 Wyrwich KW, Bullinger M, Aaronson N, Hays RD, Patrick DL, Symonds T. Estimating clinically significant differences in quality of life outcomes. Quality of Life Research : An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation. 14: 285-95. PMID 15892420 DOI: 10.1007/S11136-004-0705-2  0.4
2005 Bleiker EMA, Menko FH, Taal BG, Kluijt I, Wever LDV, Gerritsma MA, Vasen HFA, Aaronson NK. Screening behavior of individuals at high risk for colorectal cancer Gastroenterology. 128: 280-287. PMID 15685539 DOI: 10.1053/J.Gastro.2004.11.002  0.301
2004 Bjorner JB, Petersen MA, Groenvold M, Aaronson N, Ahlner-elmqvist M, Arraras JI, Brédart A, Fayers P, Jordhoy M, Sprangers M, Watson M, Young T. Use of item response theory to develop a shortened version of the EORTC QLQ-C30 emotional functioning scale Quality of Life Research. 13: 1683-1697. PMID 15651539 DOI: 10.1007/S11136-004-7866-X  0.302
2004 Boogerd W, van den Bent MJ, Koehler PJ, Heimans JJ, van der Sande JJ, Aaronson NK, Hart AA, Benraadt J, Vecht ChJ. The relevance of intraventricular chemotherapy for leptomeningeal metastasis in breast cancer: a randomised study. European Journal of Cancer (Oxford, England : 1990). 40: 2726-33. PMID 15571954 DOI: 10.1016/J.Ejca.2004.08.012  0.362
2004 Osborne RH, Sali A, Aaronson NK, Elsworth GR, Mdzewski B, Sinclair AJ. Immune function and adjustment style: do they predict survival in breast cancer? Psycho-Oncology. 13: 199-210. PMID 15022155 DOI: 10.1002/Pon.723  0.343
2004 Noorda EM, Kreij RH, Vrouenraets BC, Nieweg OE, Muller M, Kroon BB, Aaronson NK. Quality of life in long-term survivors after isolated limb perfusion for melanoma of the limbs Annals of Surgical Oncology. 11: S76-S77. DOI: 10.1007/Bf02524052  0.32
2003 Klein M, Postma TJ, Taphoorn MJ, Aaronson NK, Vandertop WP, Muller M, van der Ploeg HM, Heimans JJ. The prognostic value of cognitive functioning in the survival of patients with high-grade glioma. Neurology. 61: 1796-8. PMID 14694052 DOI: 10.1212/01.Wnl.0000098892.33018.4C  0.314
2003 Klein M, Engelberts NH, van der Ploeg HM, Kasteleijn-Nolst Trenité DG, Aaronson NK, Taphoorn MJ, Baaijen H, Vandertop WP, Muller M, Postma TJ, Heimans JJ. Epilepsy in low-grade gliomas: the impact on cognitive function and quality of life. Annals of Neurology. 54: 514-20. PMID 14520665 DOI: 10.1002/Ana.10712  0.3
2003 Bleiker EMA, Hahn DEE, Aaronson NK. Psychosocial issues in cancer genetics: Current status and future directions Acta Oncologica. 42: 276-286. PMID 12899498 DOI: 10.1080/02841860310004391  0.308
2003 De Haes JCJM, Curran D, Aaronson NK, Fentiman IS. Quality of life in breast cancer patients aged over 70 years, participating in the EORTC 10850 randomised clinical trial European Journal of Cancer. 39: 945-951. PMID 12706363 DOI: 10.1016/S0959-8049(03)00149-7  0.443
2003 Penson DF, Litwin MS, Aaronson NK. Health related quality of life in men with prostate cancer Journal of Urology. 169: 1653-1661. PMID 12686803 DOI: 10.1097/01.ju.0000061964.49961.55  0.323
2003 Fosså SD, de Wit R, Roberts JT, Wilkinson PM, de Mulder PH, Mead GM, Cook P, de Prijck L, Stenning S, Aaronson NK, Bottomley A, Collette L. Quality of life in good prognosis patients with metastatic germ cell cancer: a prospective study of the European Organization for Research and Treatment of Cancer Genitourinary Group/Medical Research Council Testicular Cancer Study Group (30941/TE20). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 21: 1107-18. PMID 12637478  0.309
2002 Van Luijn HE, Musschenga AW, Keus RB, Robinson WM, Aaronson NK. Assessment of the risk/benefit ratio of phase II cancer clinical trials by Institutional Review Board (IRB) members. Annals of Oncology : Official Journal of the European Society For Medical Oncology. 13: 1307-13. PMID 12181256 DOI: 10.1093/Annonc/Mdf209  0.327
2002 Langendijk JA, Aaronson NK, de Jong JM, ten Velde GP, Muller MJ, Slotman BJ, Wouters EF. Quality of life after curative radiotherapy in Stage I non-small-cell lung cancer. International Journal of Radiation Oncology, Biology, Physics. 53: 847-53. PMID 12095549 DOI: 10.1016/S0360-3016(02)02847-X  0.391
2002 Curran D, Molenberghs G, Aaronson NK, Fossa SD, Sylvester RJ. Analysing longitudinal continuous quality of life data with dropout. Statistical Methods in Medical Research. 11: 5-23. PMID 11923994 DOI: 10.1191/0962280202Sm270Ra  0.382
2002 Hagedoorn M, Sneeuw KC, Aaronson NK. Changes in physical functioning and quality of life in patients with cancer: response shift and relative evaluation of one's condition. Journal of Clinical Epidemiology. 55: 176-83. PMID 11809356 DOI: 10.1016/S0895-4356(01)00438-3  0.433
2002 Sloan JA, Aaronson N, Cappelleri JC, Fairclough DL, Varricchio C. Assessing the clinical significance of single items relative to summated scores. Mayo Clinic Proceedings. 77: 479-487. DOI: 10.4065/77.5.479  0.366
2002 Chassany O, Sagnier P, Marquis P, Fullerton S, Aaronson N. Patient-Reported Outcomes: The Example of Health-Related Quality of Life—A European Guidance Document for the Improved Integration of Health-Related Quality of Life Assessment in the Drug Regulatory Process: Drug Information Journal. 36: 209-238. DOI: 10.1177/009286150203600127  0.421
2001 Klein M, Taphoorn MJ, Heimans JJ, van der Ploeg HM, Vandertop WP, Smit EF, Leenstra S, Tulleken CA, Boogerd W, Belderbos JS, Cleijne W, Aaronson NK. Neurobehavioral status and health-related quality of life in newly diagnosed high-grade glioma patients. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 19: 4037-47. PMID 11600605 DOI: 10.1200/Jco.2001.19.20.4037  0.407
2001 Putten JWGv, Baas P, Codrington H, Kwa H, Muller M, Aaronson N, Groen HJM. Activity of single-agent gemcitabine as second-line treatment after previous chemotherapy or radiotherapy in advanced non-small-cell lung cancer. Lung Cancer. 33: 289-298. PMID 11551424 DOI: 10.1016/S0169-5002(01)00188-X  0.384
2001 Langendijk JA, Aaronson NK, de Jong JM, ten Velde GP, Muller MJ, Lamers RJ, Slotman BJ, Wouters EF. Prospective study on quality of life before and after radical radiotherapy in non-small-cell lung cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 19: 2123-33. PMID 11304764 DOI: 10.1200/Jco.2001.19.8.2123  0.431
2001 Detmar SB, Muller MJ, Wever LD, Schornagel JH, Aaronson NK. The patient-physician relationship. Patient-physician communication during outpatient palliative treatment visits: an observational study. Jama. 285: 1351-7. PMID 11255393 DOI: 10.1001/Jama.285.10.1351  0.374
2001 Langendijk H, de Jong J, Tjwa M, Muller M, ten Velde G, Aaronson N, Lamers R, Slotman B, Wouters M. External irradiation versus external irradiation plus endobronchial brachytherapy in inoperable non-small cell lung cancer: a prospective randomized study. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 58: 257-68. PMID 11230886 DOI: 10.1016/S0167-8140(00)00345-5  0.364
2001 Sneeuw KC, Albertsen PC, Aaronson NK. Comparison of patient and spouse assessments of health related quality of life in men with metastatic prostate cancer. The Journal of Urology. 165: 478-82. PMID 11176400 DOI: 10.1097/00005392-200102000-00029  0.34
2001 Collins G, Bottomley A, Fayers P, de Graeff A, Groenvold M, Petersen M, Aaronson N, Sprangers M. PCN17: PSYCHOMETRIC PROPERTIES OF THE EORTC QUALITY OF LIFE CORE QUESTIONNAIRE (QLQ-C30) IN EORTC TRIALS Value in Health. 4: 437-438. DOI: 10.1016/S1098-3015(11)71577-7  0.371
2001 Collins G, Bottomley A, Fayers P, de Graeff A, Groenvold M, Petersen M, Aaronson N, Sprangers M. Psychometric properties of the EORTC quality of life core questionnaire (QLQ-C30) in EORTC trials European Journal of Cancer. 37: S351-S352. DOI: 10.1016/S0959-8049(01)81798-6  0.371
2000 Langendijk JA, Aaronson NK, ten Velde GP, de Jong JM, Muller MJ, Wouters EF. Pretreatment quality of life of inoperable non-small cell lung cancer patients referred for primary radiotherapy. Acta Oncologica (Stockholm, Sweden). 39: 949-58. PMID 11207002 DOI: 10.1080/02841860050215936  0.417
2000 Detmar SB, Aaronson NK, Wever LD, Muller M, Schornagel JH. How are you feeling? Who wants to know? Patients' and oncologists' preferences for discussing health-related quality-of-life issues. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 18: 3295-301. PMID 10986063 DOI: 10.1200/Jco.2000.18.18.3295  0.431
2000 Lønning PE, Bajetta E, Murray R, Tubiana-Hulin M, Eisenberg PD, Mickiewicz E, Celio L, Pitt P, Mita M, Aaronson NK, Fowst C, Arkhipov A, di Salle E, Polli A, Massimini G. Activity of exemestane in metastatic breast cancer after failure of nonsteroidal aromatase inhibitors: a phase II trial. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 18: 2234-44. PMID 10829043 DOI: 10.1200/Jco.2000.18.11.2234  0.311
2000 Langendijk H, Aaronson NK, de Jong JM, ten Velde GP, Muller MJ, Wouters M. The prognostic impact of quality of life assessed with the EORTC QLQ-C30 in inoperable non-small cell lung carcinoma treated with radiotherapy. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 55: 19-25. PMID 10788684 DOI: 10.1016/S0167-8140(00)00158-4  0.385
2000 Curran D, Aaronson N, Standaert B, Molenberghs G, Therasse P, Ramirez A, Koopmanschap M, Erder H, Piccart M. Summary measures and statistics in the analysis of quality of life data: an example from an EORTC-NCIC-SAKK locally advanced breast cancer study. European Journal of Cancer (Oxford, England : 1990). 36: 834-44. PMID 10785587 DOI: 10.1016/S0959-8049(00)00056-3  0.396
2000 de Haes J, Curran D, Young T, Bottomley A, Flechtner H, Aaronson N, Blazeby J, Bjordal K, Brandberg Y, Greimel E, Maher J, Sprangers M, Cull A. Quality of life evaluation in oncological clinical trials - the EORTC model. The EORTC Quality of Life Study Group. European Journal of Cancer (Oxford, England : 1990). 36: 821-5. PMID 10785585 DOI: 10.1016/S0959-8049(00)00007-1  0.413
2000 Fosså SD, Curran D, Aaronson NK, Keuppens F, Kliment J, Robinson MR, DeReijke TM, Hetherington J, Kil PJ, Rea LA. Quality of life of patients with newly diagnosed poor prognosis M1 prostate cancer undergoing orchiectomy without or with mitomycin C. Results from the EORTC Phase-III trial 30893. European Urology. 37: 541-51. PMID 10765092 DOI: 10.1159/000020191  0.399
2000 Langendijk JA, ten Velde GP, Aaronson NK, de Jong JM, Muller MJ, Wouters EF. Quality of life after palliative radiotherapy in non-small cell lung cancer: a prospective study. International Journal of Radiation Oncology, Biology, Physics. 47: 149-55. PMID 10758317 DOI: 10.1016/S0360-3016(99)00540-4  0.398
1999 Sneeuw KC, Aaronson NK, Sprangers MA, Detmar SB, Wever LD, Schornagel JH. Evaluating the quality of life of cancer patients: assessments by patients, significant others, physicians and nurses. British Journal of Cancer. 81: 87-94. PMID 10487617 DOI: 10.1038/Sj.Bjc.6690655  0.479
1999 Sprangers MA, te Velde A, Aaronson NK. The construction and testing of the EORTC colorectal cancer-specific quality of life questionnaire module (QLQ-CR38). European Organization for Research and Treatment of Cancer Study Group on Quality of Life. European Journal of Cancer (Oxford, England : 1990). 35: 238-47. PMID 10448266 DOI: 10.1016/S0959-8049(98)00357-8  0.437
1999 Groenvold M, Fayers PM, Sprangers MA, Bjorner JB, Klee MC, Aaronson NK, Bech P, Mouridsen HT. Anxiety and depression in breast cancer patients at low risk of recurrence compared with the general population: a valid comparison? Journal of Clinical Epidemiology. 52: 523-30. PMID 10408991 DOI: 10.1016/S0895-4356(99)00022-0  0.332
1999 Kiebert GM, Curran D, Aaronson NK, Bolla M, Menten J, Rutten EH, Nordman E, Silvestre ME, Pierart M, Karim AB. Quality of life after radiation therapy of cerebral low-grade gliomas of the adult: results of a randomised phase III trial on dose response (EORTC trial 22844). EORTC Radiotherapy Co-operative Group. European Journal of Cancer (Oxford, England : 1990). 34: 1902-9. PMID 10023313 DOI: 10.1016/S0959-8049(98)00268-8  0.369
1999 Chassany O, Fullerton S, Sagnier P, Aaronson N, Marquis P. TPQ3: EUROPEAN GUIDANCE DOCUMENT FOR THE IMPROVEMENT OF THE INTEGRATION OF HEALTH-RELATED QUALITY OF LIFE (HRQL) ASSESSMENT IN THE DRUG REGULATORY PROCESS Value in Health. 2: 371-372. DOI: 10.1016/S1098-3015(10)75812-5  0.351
1998 Detmar SB, Aaronson NK. Quality of life assessment in daily clinical oncology practice: a feasibility study. European Journal of Cancer (Oxford, England : 1990). 34: 1181-6. PMID 9849476 DOI: 10.1016/S0959-8049(98)00018-5  0.431
1998 Raczek AE, Ware JE, Bjorner JB, Gandek B, Haley SM, Aaronson NK, Apolone G, Bech P, Brazier JE, Bullinger M, Sullivan M. Comparison of Rasch and summated rating scales constructed from SF-36 physical functioning items in seven countries: results from the IQOLA Project. International Quality of Life Assessment. Journal of Clinical Epidemiology. 51: 1203-14. PMID 9817138 DOI: 10.1016/S0895-4356(98)00112-7  0.301
1998 Keller SD, Ware JE, Bentler PM, Aaronson NK, Alonso J, Apolone G, Bjorner JB, Brazier J, Bullinger M, Kaasa S, Leplège A, Sullivan M, Gandek B. Use of structural equation modeling to test the construct validity of the SF-36 Health Survey in ten countries: results from the IQOLA Project. International Quality of Life Assessment. Journal of Clinical Epidemiology. 51: 1179-88. PMID 9817136 DOI: 10.1016/S0895-4356(98)00110-3  0.306
1998 Gandek B, Ware JE, Aaronson NK, Apolone G, Bjorner JB, Brazier JE, Bullinger M, Kaasa S, Leplege A, Prieto L, Sullivan M. Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. International Quality of Life Assessment. Journal of Clinical Epidemiology. 51: 1171-8. PMID 9817135 DOI: 10.1016/S0895-4356(98)00109-7  0.32
1998 Ware JE, Kosinski M, Gandek B, Aaronson NK, Apolone G, Bech P, Brazier J, Bullinger M, Kaasa S, Leplège A, Prieto L, Sullivan M. The factor structure of the SF-36 Health Survey in 10 countries: results from the IQOLA Project. International Quality of Life Assessment. Journal of Clinical Epidemiology. 51: 1159-65. PMID 9817133 DOI: 10.1016/S0895-4356(98)00107-3  0.302
1998 Sneeuw KC, Aaronson NK, Sprangers MA, Detmar SB, Wever LD, Schornagel JH. Comparison of patient and proxy EORTC QLQ-C30 ratings in assessing the quality of life of cancer patients. Journal of Clinical Epidemiology. 51: 617-31. PMID 9674669 DOI: 10.1016/S0895-4356(98)00040-7  0.455
1998 Curran D, van Dongen JP, Aaronson NK, Kiebert G, Fentiman IS, Mignolet F, Bartelink H. Quality of life of early-stage breast cancer patients treated with radical mastectomy or breast-conserving procedures: results of EORTC Trial 10801. The European Organization for Research and Treatment of Cancer (EORTC), Breast Cancer Co-operative Group (BCCG). European Journal of Cancer (Oxford, England : 1990). 34: 307-14. PMID 9640214 DOI: 10.1016/S0959-8049(97)00312-2  0.435
1998 Sprangers MA, Cull A, Groenvold M, Bjordal K, Blazeby J, Aaronson NK. The European Organization for Research and Treatment of Cancer approach to developing questionnaire modules: an update and overview. EORTC Quality of Life Study Group. Quality of Life Research : An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation. 7: 291-300. PMID 9610213 DOI: 10.1023/A:1024977728719  0.44
1998 Kiebert GM, Curran D, Aaronson NK. Quality of life as an endpoint in EORTC clinical trials. European Organization for Research and Treatment for Cancer. Statistics in Medicine. 17: 561-9. PMID 9549805 DOI: 10.1002/(Sici)1097-0258(19980315/15)17:5/7<561::Aid-Sim803>3.0.Co;2-S  0.438
1998 Hilgers FJ, Ackerstaff AH, Balm AJ, Tan IB, Aaronson NK, Persson JO. Development and clinical evaluation of a second-generation voice prosthesis (Provox 2), designed for anterograde and retrograde insertion. Acta Oto-Laryngologica. 117: 889-96. PMID 9442833 DOI: 10.3109/00016489709114220  0.345
1998 Detmar S, Aaronson N, Wever L, Tuijl van C, Muller M, Schornagel J. The discussion of quality of life issues during outpatient cancer consultations Patient Education and Counseling. 34: S22. DOI: 10.1016/S0738-3991(98)90045-3  0.42
1997 Curran D, Fossa SD, Aaronson N, Kiebert G, Keuppens E, Hall R. Baseline quality of life of patients with advanced prostate cancer European Journal of Cancer. 33: 1809-1814. PMID 9470838 DOI: 10.1016/S0959-8049(97)00187-1  0.445
1997 Bleiker EM, Aaronson NK, Menko FH, Hahn DE, van Asperen CJ, Rutgers EJ, ten Kate LP, Leschot NJ. Genetic counseling for hereditary cancer: a pilot study on experiences of patients and family members. Patient Education and Counseling. 32: 107-16. PMID 9355578 DOI: 10.1016/S0738-3991(97)00067-0  0.352
1997 Sneeuw KC, Aaronson NK, de Haan RJ, Limburg M. Assessing quality of life after stroke. The value and limitations of proxy ratings. Stroke; a Journal of Cerebral Circulation. 28: 1541-9. PMID 9259746  0.531
1997 Osoba D, Aaronson NK, Muller M, Sneeuw K, Hsu MA, Yung WK, Brada M, Newlands E. Effect of neurological dysfunction on health-related quality of life in patients with high-grade glioma. Journal of Neuro-Oncology. 34: 263-78. PMID 9258818 DOI: 10.1023/A:1005790632126  0.457
1997 Groenvold M, Klee MC, Sprangers MA, Aaronson NK. Validation of the EORTC QLQ-C30 quality of life questionnaire through combined qualitative and quantitative assessment of patient-observer agreement. Journal of Clinical Epidemiology. 50: 441-50. PMID 9179103 DOI: 10.1016/S0895-4356(96)00428-3  0.453
1997 Osoba O, Aaronson N, Zee B, Sprangers M, Te Velde A. Modification of the EORTC QLQ-C30 (version 2.0) based on content validity and reliability testing in large samples of patients with cancer Quality of Life Research. 6: 103-108. PMID 9161109 DOI: 10.1023/A:1026429831234  0.411
1997 Sneeuw KC, Aaronson NK, Osoba D, Muller MJ, Hsu MA, Yung WK, Brada M, Newlands ES. The use of significant others as proxy raters of the quality of life of patients with brain cancer. Medical Care. 35: 490-506. PMID 9140337 DOI: 10.1097/00005650-199705000-00006  0.485
1997 Sneeuw KC, Aaronson NK, Sprangers MA, Detmar SB, Wever LD, Schornagel JH. Value of caregiver ratings in evaluating the quality of life of patients with cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 15: 1206-17. PMID 9060565 DOI: 10.1200/Jco.1997.15.3.1206  0.435
1997 Fossa S, Curran D, Keuppens F, Kliment J, Robinson M, Rea L, Aaronson N. An III study comparing orchidectomy (Ctr) and orchidectomy plus mitomycin C (Exp: 15 mg/m2 intravenously q6 wks until progression) with respect to quality of life In patients with poor prognosis M1 prostate cancer European Journal of Cancer. 33: S29. DOI: 10.1016/S0959-8049(97)84504-2  0.362
1996 Anderson RT, Aaronson NK, Bullinger M, McBee WL. A review of the progress towards developing health-related quality-of-life instruments for international clinical studies and outcomes research. Pharmacoeconomics. 10: 336-55. PMID 10163577 DOI: 10.2165/00019053-199610040-00004  0.415
1996 Osoba D, Aaronson NK, Muller M, Sneeuw K, Hsu MA, Yung WK, Brada M, Newlands E. The development and psychometric validation of a brain cancer quality-of-life questionnaire for use in combination with general cancer-specific questionnaires. Quality of Life Research : An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation. 5: 139-50. PMID 8901377 DOI: 10.1007/Bf00435979  0.422
1996 te Velde A, Sprangers MA, Aaronson NK. Feasibility, psychometric performance, and stability across modes of administration of the CARES-SF. Annals of Oncology : Official Journal of the European Society For Medical Oncology. 7: 381-90. PMID 8805930 DOI: 10.1093/Oxfordjournals.Annonc.A010605  0.374
1996 De Boer JB, Sprangers MA, Aaronson NK, Lange JM, van Dam FS. A study of the reliability, validity and responsiveness of the HIV overview of problems evaluation system (HOPES) in assessing the quality of life of patients with AIDS and symptomatic HIV infection. Quality of Life Research : An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation. 5: 339-47. PMID 8763802 DOI: 10.1007/Bf00433918  0.363
1996 da Silva FC, Fossa SD, Aaronson NK, Serbouti S, Denis L, Casselman J, Whelan P, Hetherington J, Fava C, Richards B, Robinson MR. The quality of life of patients with newly diagnosed M1 prostate cancer: experience with EORTC clinical trial 30853. European Journal of Cancer (Oxford, England : 1990). 32: 72-7. PMID 8695246 DOI: 10.1016/0959-8049(95)00402-5  0.453
1996 Ackerstaff AH, Hilgers FJ, Aaronson NK, De Boer MF, Meeuwis CA, Knegt PP, Spoelstra HA, Van Zandwijk N, Balm AJ. Heat and moisture exchangers as a treatment option in the post-operative rehabilitation of laryngectomized patients. Clinical Otolaryngology and Allied Sciences. 20: 504-9. PMID 8665707 DOI: 10.1111/J.1365-2273.1995.Tb01589.X  0.309
1996 Simons JP, Aaronson NK, Vansteenkiste JF, ten Velde GP, Muller MJ, Drenth BM, Erdkamp FL, Cobben EG, Schoon EJ, Smeets JB, Schouten HC, Demedts M, Hillen HF, Blijham GH, Wouters EF. Effects of medroxyprogesterone acetate on appetite, weight, and quality of life in advanced-stage non-hormone-sensitive cancer: a placebo-controlled multicenter study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 14: 1077-84. PMID 8648360 DOI: 10.1200/Jco.1996.14.4.1077  0.397
1996 Aaronson NK, Visser-Pol E, Leenhouts GH, Muller MJ, van der Schot AC, van Dam FS, Keus RB, Koning CC, ten Bokkel Huinink WW, van Dongen JA, Dubbelman R. Telephone-based nursing intervention improves the effectiveness of the informed consent process in cancer clinical trials. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 14: 984-96. PMID 8622050 DOI: 10.1200/Jco.1996.14.3.984  0.302
1996 Lohr K, Aaronson N, Alonso J, Burnam A, Patrick D, Perrin E, Roberts J. C16. Evaluating quality-of-life and health status instruments: development of scientific review criteria Clinical Therapeutics. 18: 30. DOI: 10.1016/S0149-2918(96)80126-3  0.372
1995 Kaasa S, Bjordal K, Aaronson N, Moum T, Wist E, Hagen S, Kvikstad A. The EORTC Core Quality of Life questionnaire (QLQ-C30): validity and reliability when analysed with patients treated with palliative radiotherapy European Journal of Cancer. 31: 2260-2263. PMID 8652253 DOI: 10.1016/0959-8049(95)00296-0  0.453
1995 Ackerstaff AH, Hilgers FJ, Aaronson NK, Balm AJ. Communication, functional disorders and lifestyle changes after total laryngectomy. Clinical Otolaryngology and Allied Sciences. 19: 295-300. PMID 7994884 DOI: 10.1111/J.1365-2273.1994.Tb01234.X  0.356
1995 de Haan RJ, Limburg M, Van der Meulen JH, Jacobs HM, Aaronson NK. Quality of life after stroke. Impact of stroke type and lesion location. Stroke; a Journal of Cerebral Circulation. 26: 402-8. PMID 7886714  0.444
1995 Bergman B, Aaronson NK. Quality-of-life and cost-effectiveness assessment in lung cancer. Current Opinion in Oncology. 7: 138-43. PMID 7756378 DOI: 10.1097/00001622-199503000-00008  0.304
1995 Sprangers MA, Taal BG, Aaronson NK, te Velde A. Quality of life in colorectal cancer. Stoma vs. nonstoma patients. Diseases of the Colon and Rectum. 38: 361-9. PMID 7720441 DOI: 10.1007/Bf02054222  0.435
1995 de Haan R, Limburg M, Bossuyt P, van der Meulen J, Aaronson N. The clinical meaning of Rankin 'handicap' grades after stroke. Stroke; a Journal of Cerebral Circulation. 26: 2027-30. PMID 7482643 DOI: 10.1161/01.STR.26.11.2027  0.473
1995 Simons J, Aaronson N, Vansleenkiste J, ten Velde G, Hillen H, Blijham G, Wouters E. 877 The effects of medroxyprogesterone acetate (MPA) on appetite (AP), weight (WT) and quality of life (QL) in advanced stage cancer European Journal of Cancer. 31: S183. DOI: 10.1016/0959-8049(95)96126-X  0.426
1994 van Tulder MW, Aaronson NK, Bruning PF. The quality of life of long-term survivors of Hodgkin's disease. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 5: 153-8. PMID 8186158 DOI: 10.1093/Oxfordjournals.Annonc.A058768  0.377
1994 Franklin HR, Simonetti GP, Dubbelman AC, ten Bokkel Huinink WW, Taal BG, Wigbout G, Mandjes IA, Dalesio OB, Aaronson NK. Toxicity grading systems. A comparison between the WHO scoring system and the Common Toxicity Criteria when used for nausea and vomiting. Annals of Oncology : Official Journal of the European Society For Medical Oncology. 5: 113-7. PMID 8186153 DOI: 10.1093/Oxfordjournals.Annonc.A058760  0.331
1994 Cella DF, Wiklund I, Shumaker SA, Aaronson NK. Integrating health-related quality of life into cross-national clinical trials. Quality of Life Research : An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation. 2: 433-40. PMID 8161977 DOI: 10.1007/Bf00422217  0.349
1994 Anderson RT, Aaronson NK, Wilkin D. Critical review of the international assessments of health-related quality of life. Quality of Life Research : An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation. 2: 369-95. PMID 8161975 DOI: 10.1007/Bf00422215  0.413
1994 Bergman B, Aaronson NK, Ahmedzai S, Kaasa S, Sullivan M. The EORTC QLQ-LC13: a modular supplement to the EORTC Core Quality of Life Questionnaire (QLQ-C30) for use in lung cancer clinical trials. EORTC Study Group on Quality of Life. European Journal of Cancer (Oxford, England : 1990). 635-42. PMID 8080679 DOI: 10.1016/0959-8049(94)90535-5  0.365
1994 De Boer JB, Sprangers MA, Aaronson NK, Lange JM, Van Dam FS. The feasibility, reliability and validity of the EORTC QLQ-C30 in assessing the quality of life of patients with a symptomatic HIV infection or AIDS (CDC IV) Psychology & Health. 9: 65-77. DOI: 10.1080/08870449408407460  0.423
1994 Aaronson NK, Cull A, Kaasa S, Sprangers MA. The EORTC Modular Approach to Quality of Life Assessment in Oncology International Journal of Mental Health. 23: 75-96. DOI: 10.1080/00207411.1994.11449284  0.467
1993 Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute. 85: 365-76. PMID 8433390 DOI: 10.1093/jnci/85.5.365  0.378
1993 de Haan R, Aaronson N, Limburg M, Hewer RL, van Crevel H. Measuring quality of life in stroke. Stroke; a Journal of Cerebral Circulation. 24: 320-7. PMID 8421836 DOI: 10.1161/01.STR.24.2.320  0.57
1993 Sprangers MA, Cull A, Bjordal K, Groenvold M, Aaronson NK. The European Organization for Research and Treatment of Cancer. Approach to quality of life assessment: guidelines for developing questionnaire modules. EORTC Study Group on Quality of Life. Quality of Life Research : An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation. 2: 287-95. PMID 8220363 DOI: 10.1007/Bf00434800  0.438
1993 Aaronson N. Quality of life assessment: Key issues in the 1990s Quality of Life Research. 2: 305-306. DOI: 10.1007/Bf00434802  0.362
1993 Sprangers MAG, Velde AT, Aaronson NK, Taal BG. Quality of life following surgery for colorectal cancer: A literature review Psycho-Oncology. 2: 247-259. DOI: 10.1002/Pon.2960020405  0.445
1992 Sprangers MA, Aaronson NK. The role of health care providers and significant others in evaluating the quality of life of patients with chronic disease: a review. Journal of Clinical Epidemiology. 45: 743-60. PMID 1619454 DOI: 10.1016/0895-4356(92)90052-O  0.315
1992 Aaronson NK. Assessing the quality of life of patients in cancer clinical trials: Common problems and common sense solutions. European Journal of Cancer (Oxford, England : 1990). 1304-7. PMID 1515238 DOI: 10.1016/0959-8049(92)90504-U  0.437
1992 Sneeuw KC, Aaronson NK, Yarnold JR, Broderick M, Regan J, Ross G, Goddard A. Cosmetic and functional outcomes of breast conserving treatment for early stage breast cancer. 2. Relationship with psychosocial functioning. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 25: 160-6. PMID 1470692 DOI: 10.1016/0167-8140(92)90262-S  0.392
1992 Sneeuw KC, Aaronson NK, Yarnold JR, Broderick M, Regan J, Ross G, Goddard A. Cosmetic and functional outcomes of breast conserving treatment for early stage breast cancer. 1. Comparison of patients' ratings, observers' ratings, and objective assessments. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 25: 153-9. PMID 1470691 DOI: 10.1016/0167-8140(92)90261-R  0.376
1991 Hilgers FJ, Ackerstaff AH, Aaronson NK, Schouwenburg PF, Van Zandwijk N. Physical and psychosocial consequences of total laryngectomy. Clinical Otolaryngology and Allied Sciences. 15: 421-5. PMID 2282704 DOI: 10.1111/J.1365-2273.1990.Tb00494.X  0.34
1991 Aaronson NK. Methodologic issues in assessing the quality of life of cancer patients. Cancer. 67: 844-50. PMID 1986856 DOI: 10.1002/1097-0142(19910201)67:3+<844::Aid-Cncr2820671416>3.0.Co;2-B  0.471
1991 Aaronson NK, Meyerowitz BE, Bard M, Bloom JR, Fawzy FI, Feldstein M, Fink D, Holland JC, Johnson JE, Lowman JT. Quality of life research in oncology. Past achievements and future priorities. Cancer. 67: 839-43. PMID 1986855 DOI: 10.1002/1097-0142(19910201)67:3+<839::Aid-Cncr2820671415>3.0.Co;2-0  0.402
1991 van Holten-Verzantvoort AT, Zwinderman AH, Aaronson NK, Hermans J, van Emmerik B, van Dam FS, van den Bos B, Bijvoet OL, Cleton FJ. The effect of supportive pamidronate treatment on aspects of quality of life of patients with advanced breast cancer. European Journal of Cancer (Oxford, England : 1990). 27: 544-9. PMID 1675865 DOI: 10.1016/0277-5379(91)90212-V  0.425
1991 Aaronson NK. Quality of life assessments in clinical trials Controlled Clinical Trials. 12: 351-352. DOI: 10.1016/0197-2456(91)90032-H  0.372
1990 Aaronson NK. Quality of life assessment in clinical trials: methodologic issues. Controlled Clinical Trials. 10: 195S-208S. PMID 2605968 DOI: 10.1016/0197-2456(89)90058-5  0.426
1990 Fossa SD, Aaronson NK, Newling D, Cangh PJv, Denis L, Kurth KH, Pauw Md. Quality of life and treatment of hormone resistant metastatic prostatic cancer European Journal of Cancer and Clinical Oncology. 26: 1133-1136. PMID 2149995 DOI: 10.1016/0277-5379(90)90269-Y  0.44
1989 Aaronson NK. Quantitative issues in health-related quality of life assessment. Health Policy (Amsterdam, Netherlands). 10: 217-30. PMID 10291115 DOI: 10.1016/0168-8510(88)90058-9  0.401
1989 Aaronson NK. The assessment of subjective response in prostatic cancer clinical research. American Journal of Clinical Oncology. S43-7. PMID 3071953 DOI: 10.1097/00000421-198801102-00010  0.412
1989 Fosså SD, Aaronson N, Calais da Silva F, Denis L, Newling D, Hosbach G, Kaalhus O. Quality of life in patients with muscle-infiltrating bladder cancer and hormone-resistant prostatic cancer. European Urology. 16: 335-9. PMID 2476317 DOI: 10.1159/000471611  0.374
1988 Aaronson NK, Bullinger M, Ahmedzai S. A modular approach to quality-of-life assessment in cancer clinical trials. Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progrã¨S Dans Les Recherches Sur Le Cancer. 111: 231-49. PMID 2459750 DOI: 10.1007/978-3-642-83419-6_27  0.31
1987 Aaronson NK, van Dam FSAM, Polak CE, Zittoun R. Prospects and Problems in European Psychosocial Oncology Journal of Psychosocial Oncology. 4: 43-53. DOI: 10.1300/J077V04N04_04  0.412
1985 Aaronson NK. Assessment of quality of life in clinical trials of cardiovascular therapies Controlled Clinical Trials. 6: 318-319. DOI: 10.1016/0197-2456(85)90107-2  0.355
Show low-probability matches.